| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | EFCAB5 PCDHA9 ADGRV1 ITPR1 DST PLS3 PLCZ1 ANXA2P2 PCDHB6 PCDHB3 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 TGM3 HMCN1 SLIT3 ANXA10 MACF1 | 1.98e-08 | 749 | 208 | 27 | GO:0005509 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 8.97e-07 | 18 | 208 | 5 | GO:0008569 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 2.11e-06 | 37 | 208 | 6 | GO:0045505 | |
| GeneOntologyMolecularFunction | androsterone dehydrogenase (B-specific) activity | 4.42e-06 | 4 | 208 | 3 | GO:0047042 | |
| GeneOntologyMolecularFunction | ketoreductase activity | 4.42e-06 | 4 | 208 | 3 | GO:0045703 | |
| GeneOntologyMolecularFunction | chlordecone reductase activity | 4.42e-06 | 4 | 208 | 3 | GO:0047743 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | NGEF DENND5A VAV1 KALRN ARHGEF18 DENND11 DENND3 GNA13 SBF2 DENND2C KNDC1 SOS2 | 5.83e-06 | 231 | 208 | 12 | GO:0005085 |
| GeneOntologyMolecularFunction | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity | 1.10e-05 | 5 | 208 | 3 | GO:0047115 | |
| GeneOntologyMolecularFunction | 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity | 1.10e-05 | 5 | 208 | 3 | GO:0047020 | |
| GeneOntologyMolecularFunction | 17-beta-ketosteroid reductase (NADPH) activity | 1.10e-05 | 5 | 208 | 3 | GO:0072555 | |
| GeneOntologyMolecularFunction | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity | 1.10e-05 | 5 | 208 | 3 | GO:0047006 | |
| GeneOntologyMolecularFunction | lithocholic acid binding | 1.10e-05 | 5 | 208 | 3 | GO:1902121 | |
| GeneOntologyMolecularFunction | ketosteroid monooxygenase activity | 1.10e-05 | 5 | 208 | 3 | GO:0047086 | |
| GeneOntologyMolecularFunction | Delta4-3-oxosteroid 5beta-reductase activity | 1.10e-05 | 5 | 208 | 3 | GO:0047787 | |
| GeneOntologyMolecularFunction | sodium channel activity | 1.62e-05 | 52 | 208 | 6 | GO:0005272 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCA1 MYO5B ABCA13 COQ8B MCM6 DDX6 ABCB1 IFIH1 DNAH8 DNAH9 DYNC1H1 DNAH3 ABCB9 MACF1 ATP2B4 AFG1L | 1.65e-05 | 441 | 208 | 16 | GO:0016887 |
| GeneOntologyMolecularFunction | geranylgeranyl reductase activity | 2.18e-05 | 6 | 208 | 3 | GO:0045550 | |
| GeneOntologyMolecularFunction | 17-beta-hydroxysteroid dehydrogenase (NADP+) activity | 3.78e-05 | 7 | 208 | 3 | GO:0072582 | |
| GeneOntologyMolecularFunction | 5alpha-androstane-3beta,17beta-diol dehydrogenase activity | 6.00e-05 | 8 | 208 | 3 | GO:0047024 | |
| GeneOntologyMolecularFunction | androsterone dehydrogenase activity | 6.00e-05 | 8 | 208 | 3 | GO:0047023 | |
| GeneOntologyMolecularFunction | enone reductase activity | 6.00e-05 | 8 | 208 | 3 | GO:0035671 | |
| GeneOntologyMolecularFunction | androstan-3-alpha,17-beta-diol dehydrogenase activity | 8.94e-05 | 9 | 208 | 3 | GO:0047044 | |
| GeneOntologyMolecularFunction | NADP+ binding | 8.94e-05 | 9 | 208 | 3 | GO:0070401 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | PKD1L1 CALHM4 ITPR1 CLCA1 TRPM3 MLC1 SCN4A SCN5A SCN8A SCN10A KCNN2 APOL2 MCOLN1 SLC1A4 MCOLN3 | 9.90e-05 | 459 | 208 | 15 | GO:0005216 |
| GeneOntologyMolecularFunction | testosterone 17-beta-dehydrogenase (NADP+) activity | 1.27e-04 | 10 | 208 | 3 | GO:0047045 | |
| GeneOntologyMolecularFunction | bile acid binding | 1.27e-04 | 10 | 208 | 3 | GO:0032052 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 1.43e-04 | 26 | 208 | 4 | GO:0005248 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ABCA1 MYO5B ABCA13 COQ8B MCM6 DDX6 ABCB1 IFIH1 DNAH8 DNAH9 DYNC1H1 DNAH3 ARHGAP5 RAB34 ABCB9 GNA13 MACF1 SEPTIN10 ATP2B4 AFG1L | 1.82e-04 | 775 | 208 | 20 | GO:0017111 |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.92e-04 | 28 | 208 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCA1 MYO5B ABCA13 COQ8B MCM6 DDX6 ABCB1 IFIH1 KIFC3 DNAH8 DNAH9 DYNC1H1 DNAH3 ABCB9 MACF1 ATP2B4 AFG1L | 2.51e-04 | 614 | 208 | 17 | GO:0140657 |
| GeneOntologyMolecularFunction | aldose reductase (NADPH) activity | 3.73e-04 | 14 | 208 | 3 | GO:0004032 | |
| GeneOntologyMolecularFunction | retinal dehydrogenase activity | 3.73e-04 | 14 | 208 | 3 | GO:0001758 | |
| GeneOntologyMolecularFunction | channel activity | PKD1L1 CALHM4 ITPR1 CLCA1 TRPM3 MLC1 SCN4A SCN5A SCN8A SCN10A KCNN2 APOL2 MCOLN1 SLC1A4 MCOLN3 | 4.19e-04 | 525 | 208 | 15 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | PKD1L1 CALHM4 ITPR1 CLCA1 TRPM3 MLC1 SCN4A SCN5A SCN8A SCN10A KCNN2 APOL2 MCOLN1 SLC1A4 MCOLN3 | 4.28e-04 | 526 | 208 | 15 | GO:0022803 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ABCA1 MYO5B ABCA13 COQ8B MCM6 DDX6 ABCB1 IFIH1 DNAH8 DNAH9 DYNC1H1 DNAH3 ARHGAP5 RAB34 ABCB9 GNA13 MACF1 SEPTIN10 ATP2B4 AFG1L | 5.06e-04 | 839 | 208 | 20 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ABCA1 MYO5B ABCA13 COQ8B MCM6 DDX6 ABCB1 IFIH1 DNAH8 DNAH9 DYNC1H1 DNAH3 ARHGAP5 RAB34 ABCB9 GNA13 MACF1 SEPTIN10 ATP2B4 AFG1L | 5.14e-04 | 840 | 208 | 20 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ABCA1 MYO5B ABCA13 COQ8B MCM6 DDX6 ABCB1 IFIH1 DNAH8 DNAH9 DYNC1H1 DNAH3 ARHGAP5 RAB34 ABCB9 GNA13 MACF1 SEPTIN10 ATP2B4 AFG1L | 5.14e-04 | 840 | 208 | 20 | GO:0016818 |
| GeneOntologyMolecularFunction | indanol dehydrogenase activity | 6.39e-04 | 4 | 208 | 2 | GO:0047718 | |
| GeneOntologyMolecularFunction | sphingolipid floppase activity | 6.39e-04 | 4 | 208 | 2 | GO:0046623 | |
| GeneOntologyMolecularFunction | lipid binding | ABCA1 STARD8 COQ8B ADGRB1 WASHC2A AKR1C1 AKR1C2 SNX13 ITPR1 RPS6KC1 APOL2 FERMT3 PLCZ1 WASHC2C ANXA2P2 APOB MCOLN1 SBF2 ANXA10 AKR1C3 INSIG2 MCOLN3 | 6.63e-04 | 988 | 208 | 22 | GO:0008289 |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 8.10e-04 | 18 | 208 | 3 | GO:0015278 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 8.17e-04 | 70 | 208 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | STARD8 NGEF DENND5A VAV1 KALRN ARHGEF18 DENND11 DENND3 ARHGAP5 GNA13 SBF2 DENND2C KNDC1 SOS2 | 9.06e-04 | 507 | 208 | 14 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | STARD8 NGEF DENND5A VAV1 KALRN ARHGEF18 DENND11 DENND3 ARHGAP5 GNA13 SBF2 DENND2C KNDC1 SOS2 | 9.06e-04 | 507 | 208 | 14 | GO:0030695 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | PKD1L1 CALHM4 ITPR1 TRPM3 SCN4A SCN5A SCN8A SCN10A KCNN2 MCOLN1 MCOLN3 | 9.81e-04 | 343 | 208 | 11 | GO:0005261 |
| GeneOntologyMolecularFunction | NAADP-sensitive calcium-release channel activity | 1.06e-03 | 5 | 208 | 2 | GO:0072345 | |
| GeneOntologyMolecularFunction | estradiol 17-beta-dehydrogenase [NAD(P)+] activity | 1.11e-03 | 20 | 208 | 3 | GO:0004303 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.49e-03 | 118 | 208 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor | 1.56e-03 | 48 | 208 | 4 | GO:0016620 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3-phosphate binding | 1.56e-03 | 48 | 208 | 4 | GO:0032266 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity involved in cardiac muscle cell action potential | 1.58e-03 | 6 | 208 | 2 | GO:0086006 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 1.68e-03 | 49 | 208 | 4 | GO:0140359 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-5-phosphate binding | 1.69e-03 | 23 | 208 | 3 | GO:0010314 | |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NAD+) activity | 1.92e-03 | 24 | 208 | 3 | GO:0004745 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NAD+) activity | 2.43e-03 | 26 | 208 | 3 | GO:0004022 | |
| GeneOntologyMolecularFunction | NADPH binding | 2.43e-03 | 26 | 208 | 3 | GO:0070402 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NADP+) activity | 2.71e-03 | 27 | 208 | 3 | GO:0008106 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors | 2.75e-03 | 56 | 208 | 4 | GO:0016903 | |
| GeneOntologyMolecularFunction | phosphatidylcholine floppase activity | 2.90e-03 | 8 | 208 | 2 | GO:0090554 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase [NAD(P)+] activity | 3.68e-03 | 30 | 208 | 3 | GO:0018455 | |
| GeneOntologyMolecularFunction | G protein-coupled glutamate receptor activity | 3.70e-03 | 9 | 208 | 2 | GO:0098988 | |
| GeneOntologyMolecularFunction | peptide transmembrane transporter activity | 3.70e-03 | 9 | 208 | 2 | GO:1904680 | |
| GeneOntologyMolecularFunction | adenylate cyclase inhibiting G protein-coupled glutamate receptor activity | 3.70e-03 | 9 | 208 | 2 | GO:0001640 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | PKD1L1 CALHM4 ITPR1 CLCA1 TRPM3 MLC1 SCN4A SCN5A SCN8A SCN10A KCNN2 APOL2 MCOLN1 SLC1A4 SLC15A1 ATP2B4 MCOLN3 | 4.00e-03 | 793 | 208 | 17 | GO:0015075 |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 4.04e-03 | 31 | 208 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | aldo-keto reductase (NADPH) activity | 4.42e-03 | 32 | 208 | 3 | GO:0004033 | |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 4.48e-03 | 103 | 208 | 5 | GO:0005253 | |
| GeneOntologyMolecularFunction | retromer complex binding | 4.60e-03 | 10 | 208 | 2 | GO:1905394 | |
| GeneOntologyMolecularFunction | histone H3K9me2 methyltransferase activity | 4.60e-03 | 10 | 208 | 2 | GO:0140947 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 4.83e-03 | 33 | 208 | 3 | GO:0005217 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 4.83e-03 | 33 | 208 | 3 | GO:0033764 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 5.08e-03 | 151 | 208 | 6 | GO:0015085 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor | 5.26e-03 | 34 | 208 | 3 | GO:0016628 | |
| GeneOntologyMolecularFunction | testosterone dehydrogenase [NAD(P)+] activity | 5.58e-03 | 11 | 208 | 2 | GO:0030283 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 5.69e-03 | 109 | 208 | 5 | GO:0042626 | |
| GeneOntologyMolecularFunction | pattern recognition receptor activity | 5.70e-03 | 35 | 208 | 3 | GO:0038187 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ABCA1 ABCA13 PKD1L1 CALHM4 ABCB1 ITPR1 CLCA1 TRPM3 MLC1 SCN4A SCN5A SCN8A SCN10A KCNN2 APOL2 MCOLN1 SLC1A4 SLC2A5 ABCB9 SLC15A1 ATP2B4 MCOLN3 | 5.92e-03 | 1180 | 208 | 22 | GO:0022857 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | PCDHA9 PCDHB6 PCDHB3 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 HMCN1 | 4.32e-11 | 187 | 200 | 16 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | PCDHA9 SLITRK2 PCDHB6 PCDHB3 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 COLEC10 LRRC4C HMCN1 | 2.40e-10 | 313 | 200 | 19 | GO:0098742 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | EPHB3 IL18 PCDHA9 PKD1L1 ADGRV1 NOD2 SLITRK2 NRXN3 PKHD1 DLG1 KIFC3 ALOX5 VAV1 FERMT3 PCDHB6 PCDHB3 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 GPAM PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 COLEC10 LRRC4C HMCN1 | 1.49e-08 | 1077 | 200 | 32 | GO:0098609 |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | EPHB3 TPR ABCA1 TRABD2B HDAC4 LRRC24 MYO5B ABCA13 ENTR1 ADGRB1 DEF8 FYCO1 PLXND1 ITPR1 NOD2 SLITRK2 DLG1 HSF1 DYNC1H1 NDNF TRABD2A WASHC2C KALRN ANXA2P2 SYNE1 NTRK3 COLEC10 SKIL MCOLN1 SETDB2 USP8 MACF1 HTT | 1.05e-06 | 1366 | 200 | 33 | GO:0051130 |
| GeneOntologyBiologicalProcess | parturition | 1.88e-06 | 22 | 200 | 5 | GO:0007567 | |
| GeneOntologyBiologicalProcess | response to jasmonic acid | 3.57e-06 | 4 | 200 | 3 | GO:0009753 | |
| GeneOntologyBiologicalProcess | progesterone catabolic process | 3.57e-06 | 4 | 200 | 3 | GO:0006709 | |
| GeneOntologyBiologicalProcess | C21-steroid hormone catabolic process | 3.57e-06 | 4 | 200 | 3 | GO:0008208 | |
| GeneOntologyBiologicalProcess | cellular response to jasmonic acid stimulus | 3.57e-06 | 4 | 200 | 3 | GO:0071395 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component biogenesis | EPHB3 TPR ABCA1 TRABD2B HDAC4 LRRC24 MYO5B ENTR1 ADGRB1 DEF8 SLITRK2 DLG1 HSF1 DYNC1H1 TRABD2A WASHC2C NTRK3 SETDB2 HTT | 4.21e-06 | 582 | 200 | 19 | GO:0044089 |
| GeneOntologyBiologicalProcess | sesquiterpenoid catabolic process | 8.85e-06 | 5 | 200 | 3 | GO:0016107 | |
| GeneOntologyBiologicalProcess | olefinic compound catabolic process | 8.85e-06 | 5 | 200 | 3 | GO:0120256 | |
| GeneOntologyBiologicalProcess | farnesol metabolic process | 8.85e-06 | 5 | 200 | 3 | GO:0016487 | |
| GeneOntologyBiologicalProcess | farnesol catabolic process | 8.85e-06 | 5 | 200 | 3 | GO:0016488 | |
| GeneOntologyBiologicalProcess | negative regulation of isoprenoid metabolic process | 8.85e-06 | 5 | 200 | 3 | GO:0045827 | |
| GeneOntologyBiologicalProcess | negative regulation of retinoic acid biosynthetic process | 8.85e-06 | 5 | 200 | 3 | GO:1900053 | |
| GeneOntologyBiologicalProcess | sesquiterpenoid metabolic process | 1.76e-05 | 6 | 200 | 3 | GO:0006714 | |
| GeneOntologyBiologicalProcess | polyprenol catabolic process | 1.76e-05 | 6 | 200 | 3 | GO:0016095 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 3.02e-05 | 62 | 200 | 6 | GO:0086002 | |
| GeneOntologyBiologicalProcess | response to prostaglandin D | 3.05e-05 | 7 | 200 | 3 | GO:0071798 | |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin D stimulus | 3.05e-05 | 7 | 200 | 3 | GO:0071799 | |
| GeneOntologyBiologicalProcess | regulation of retinoic acid biosynthetic process | 3.05e-05 | 7 | 200 | 3 | GO:1900052 | |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | EPHB3 TPR ABCA1 TRABD2B HDAC4 LRRC24 MYO5B CARMIL3 ENTR1 ADGRB1 DEF8 SPTBN5 SLITRK2 TGFBRAP1 DLG1 HSF1 DYNC1H1 TRABD2A WASHC2C SYNE1 NTRK3 ARHGEF18 SETDB2 GNA13 MACF1 CAPZA3 HTT | 3.36e-05 | 1189 | 200 | 27 | GO:0044087 |
| GeneOntologyBiologicalProcess | multi-pass transmembrane protein insertion into ER membrane | 7.23e-05 | 9 | 200 | 3 | GO:0160063 | |
| GeneOntologyBiologicalProcess | daunorubicin metabolic process | 7.23e-05 | 9 | 200 | 3 | GO:0044597 | |
| GeneOntologyBiologicalProcess | positive regulation of protein oxidation | 9.36e-05 | 2 | 200 | 2 | GO:1904808 | |
| GeneOntologyBiologicalProcess | regulation of protein oxidation | 9.36e-05 | 2 | 200 | 2 | GO:1904806 | |
| GeneOntologyBiologicalProcess | regulation of isoprenoid metabolic process | 1.02e-04 | 10 | 200 | 3 | GO:0019747 | |
| GeneOntologyBiologicalProcess | doxorubicin metabolic process | 1.02e-04 | 10 | 200 | 3 | GO:0044598 | |
| GeneOntologyBiologicalProcess | negative regulation of vitamin metabolic process | 1.02e-04 | 10 | 200 | 3 | GO:0046137 | |
| GeneOntologyBiologicalProcess | polyketide metabolic process | 1.02e-04 | 10 | 200 | 3 | GO:0030638 | |
| GeneOntologyBiologicalProcess | aminoglycoside antibiotic metabolic process | 1.02e-04 | 10 | 200 | 3 | GO:0030647 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 1.27e-04 | 153 | 200 | 8 | GO:0030048 | |
| GeneOntologyBiologicalProcess | regulation of testosterone biosynthetic process | 1.40e-04 | 11 | 200 | 3 | GO:2000224 | |
| GeneOntologyBiologicalProcess | terpenoid catabolic process | 1.40e-04 | 11 | 200 | 3 | GO:0016115 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 2.03e-04 | 87 | 200 | 6 | GO:0086001 | |
| GeneOntologyBiologicalProcess | cellular response to calcium ion | 2.16e-04 | 88 | 200 | 6 | GO:0071277 | |
| GeneOntologyBiologicalProcess | synapse assembly | EPHB3 LRRC24 CARMIL3 ADGRB1 PLXND1 SLITRK2 NRXN3 NTRK3 PCDHB6 PCDHB3 GNA13 | 2.20e-04 | 308 | 200 | 11 | GO:0007416 |
| GeneOntologyBiologicalProcess | regulation of Arp2/3 complex-mediated actin nucleation | 2.20e-04 | 31 | 200 | 4 | GO:0034315 | |
| GeneOntologyBiologicalProcess | positive regulation of reactive oxygen species metabolic process | 2.30e-04 | 89 | 200 | 6 | GO:2000379 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 2.43e-04 | 127 | 200 | 7 | GO:0070252 | |
| GeneOntologyBiologicalProcess | intracellular transport | TPR GPRASP1 ABCA1 MYO5B VPS13C ENTR1 TMCO6 FYCO1 WASHC2A SNX13 SPTBN5 TIMM8A DST MLC1 TGFBRAP1 EXOC6B DENND5A DYNC1H1 ERO1B WASHC2C ARV1 ANXA2P2 SYNE1 NUP214 MCOLN1 RNF126 DENND3 RAB34 HTT | 2.72e-04 | 1496 | 200 | 29 | GO:0046907 |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 2.92e-04 | 93 | 200 | 6 | GO:0086003 | |
| GeneOntologyBiologicalProcess | retinoic acid biosynthetic process | 3.02e-04 | 14 | 200 | 3 | GO:0002138 | |
| GeneOntologyBiologicalProcess | isoprenoid catabolic process | 3.02e-04 | 14 | 200 | 3 | GO:0008300 | |
| GeneOntologyBiologicalProcess | steroid catabolic process | 3.17e-04 | 34 | 200 | 4 | GO:0006706 | |
| GeneOntologyBiologicalProcess | diterpenoid biosynthetic process | 3.75e-04 | 15 | 200 | 3 | GO:0016102 | |
| GeneOntologyBiologicalProcess | synapse organization | EPHB3 LRRC24 MYO5B CARMIL3 ADGRB1 PLXND1 SLITRK2 NRXN3 NGEF DLG1 KALRN NTRK3 PCDHB6 PCDHB3 NBEA LRRC4C GNA13 | 3.86e-04 | 685 | 200 | 17 | GO:0050808 |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 3.96e-04 | 36 | 200 | 4 | GO:0086010 | |
| GeneOntologyBiologicalProcess | testosterone biosynthetic process | 4.58e-04 | 16 | 200 | 3 | GO:0061370 | |
| GeneOntologyBiologicalProcess | negative regulation of hormone metabolic process | 4.58e-04 | 16 | 200 | 3 | GO:0032351 | |
| GeneOntologyBiologicalProcess | cell junction organization | EPHB3 LRRC24 MYO5B CARMIL3 ADGRB1 PLXND1 SLITRK2 NRXN3 DST NGEF PKHD1 DLG1 KIFC3 KALRN NTRK3 PCDHB6 PCDHB3 NBEA LRRC4C GNA13 MACF1 | 5.28e-04 | 974 | 200 | 21 | GO:0034330 |
| GeneOntologyBiologicalProcess | nuclear matrix organization | 5.54e-04 | 4 | 200 | 2 | GO:0043578 | |
| GeneOntologyBiologicalProcess | calcium ion export | 5.54e-04 | 4 | 200 | 2 | GO:1901660 | |
| GeneOntologyBiologicalProcess | cardiac left ventricle formation | 5.54e-04 | 4 | 200 | 2 | GO:0003218 | |
| GeneOntologyBiologicalProcess | multi-organism reproductive process | 5.57e-04 | 290 | 200 | 10 | GO:0044703 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | EPHB3 HDAC4 MYO5B ENTR1 DEF8 PLXND1 ITPR1 NGEF DENND5A NDNF KALRN SYNE1 NTRK3 RTN4RL1 LRRC4C SKIL KNDC1 MACF1 HTT | 6.02e-04 | 846 | 200 | 19 | GO:0120035 |
| GeneOntologyBiologicalProcess | multi-multicellular organism process | 6.19e-04 | 294 | 200 | 10 | GO:0044706 | |
| GeneOntologyBiologicalProcess | negative regulation of small molecule metabolic process | 6.38e-04 | 149 | 200 | 7 | GO:0062014 | |
| GeneOntologyBiologicalProcess | regulation of actin nucleation | 6.56e-04 | 41 | 200 | 4 | GO:0051125 | |
| GeneOntologyBiologicalProcess | regulation of vitamin metabolic process | 6.58e-04 | 18 | 200 | 3 | GO:0030656 | |
| GeneOntologyBiologicalProcess | cell recognition | 7.18e-04 | 198 | 200 | 8 | GO:0008037 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | EPHB3 HDAC4 MYO5B ENTR1 DEF8 PLXND1 ITPR1 NGEF DENND5A NDNF KALRN SYNE1 NTRK3 RTN4RL1 LRRC4C SKIL KNDC1 MACF1 HTT | 7.63e-04 | 863 | 200 | 19 | GO:0031344 |
| GeneOntologyBiologicalProcess | localization within membrane | MYO5B ENTR1 TIMM8A NRXN3 NOMO2 EXOC6B DLG1 TENT2 WASHC2C KALRN ANXA2P2 NBEA NOMO1 RAB34 MACF1 ATP2B4 NOMO3 LRRC15 | 7.98e-04 | 798 | 200 | 18 | GO:0051668 |
| GeneOntologyBiologicalProcess | amide transport | ABCA1 ABCA13 PTGER3 ABCB1 ITPR1 ALOX5 KALRN CRH ABCB9 SLC15A1 C1QTNF12 HTT | 8.53e-04 | 420 | 200 | 12 | GO:0042886 |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 2.05e-05 | 17 | 208 | 4 | GO:0001518 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | ABCA1 MYO5B ADGRB1 ADGRV1 DDX6 ITPR1 DST MLC1 SCN5A PKHD1 DLG1 HSF1 ALOX5 GOLGA1 PLCZ1 KALRN ANXA2P2 SYNE1 TG RAB34 SBF2 HTT DCTN3 | 6.01e-05 | 934 | 208 | 23 | GO:0048471 |
| GeneOntologyCellularComponent | glutamatergic synapse | MYO5B CARMIL3 ADGRB1 PLXND1 SLITRK2 NRXN3 SCN8A NGEF SCN10A KCNN2 DLG1 TENT2 KALRN NTRK3 NBEA LRRC4C GRM1 GRM3 USP8 ATP2B4 HTT | 7.01e-05 | 817 | 208 | 21 | GO:0098978 |
| GeneOntologyCellularComponent | multi-pass translocon complex | 7.80e-05 | 9 | 208 | 3 | GO:0160064 | |
| GeneOntologyCellularComponent | sodium channel complex | 1.86e-04 | 29 | 208 | 4 | GO:0034706 | |
| GeneOntologyCellularComponent | dynein complex | 1.98e-04 | 54 | 208 | 5 | GO:0030286 | |
| GeneOntologyCellularComponent | postsynapse | MYO5B CARMIL3 ADGRB1 ITPR1 RPS6KC1 SLITRK2 DST SCN8A NGEF KCNN2 DLG1 TENT2 KALRN SYNE1 NTRK3 NBEA LRRC4C GRM1 GRM3 USP8 GNA13 MACF1 HTT | 2.14e-04 | 1018 | 208 | 23 | GO:0098794 |
| GeneOntologyCellularComponent | microtubule associated complex | 2.15e-04 | 161 | 208 | 8 | GO:0005875 | |
| GeneOntologyCellularComponent | synaptic membrane | ADGRB1 ITPR1 SLITRK2 NRXN3 SCN8A SCN10A KCNN2 DLG1 SYNE1 NTRK3 NBEA LRRC4C GRM1 GRM3 ATP2B4 HTT | 2.55e-04 | 583 | 208 | 16 | GO:0097060 |
| GeneOntologyCellularComponent | ER membrane insertion complex | 3.26e-04 | 14 | 208 | 3 | GO:0072379 | |
| GeneOntologyCellularComponent | early endosome | ENTR1 WASHC2A SNX13 RPS6KC1 MLC1 TGFBRAP1 WASHC2C ANXA2P2 APOB USP8 RAB34 ABCB9 MCOLN3 HTT | 3.46e-04 | 481 | 208 | 14 | GO:0005769 |
| GeneOntologyCellularComponent | endosome | ABCA1 MYO5B PRSS16 VPS13C ENTR1 FYCO1 WASHC2A TLR8 SNX13 RPS6KC1 MLC1 TGFBRAP1 WASHC2C ANXA2P2 APOB COLEC10 MCOLN1 USP8 STS RAB34 ABCB9 SBF2 MCOLN3 HTT | 6.08e-04 | 1167 | 208 | 24 | GO:0005768 |
| GeneOntologyCellularComponent | sarcolemma | 6.50e-04 | 190 | 208 | 8 | GO:0042383 | |
| GeneOntologyCellularComponent | cell cortex | MYO5B SPTBN5 DST EXOC6B DYNC1H1 ARV1 ANXA2P2 HMCN1 MACF1 CAPZA3 SEPTIN10 | 1.28e-03 | 371 | 208 | 11 | GO:0005938 |
| MousePheno | enhanced coordination | 2.72e-07 | 38 | 166 | 7 | MP:0003858 | |
| MousePheno | parturition failure | 3.81e-06 | 10 | 166 | 4 | MP:0012010 | |
| MousePheno | impaired limb coordination | 5.96e-06 | 59 | 166 | 7 | MP:0001524 | |
| MousePheno | long stride length | 2.36e-05 | 15 | 166 | 4 | MP:0010540 | |
| MousePheno | dysmyelination | 8.01e-05 | 20 | 166 | 4 | MP:0013438 | |
| Domain | Cadherin_tail | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 8.87e-17 | 37 | 210 | 13 | PF15974 |
| Domain | Cadherin_CBD | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 8.87e-17 | 37 | 210 | 13 | IPR031904 |
| Domain | Cadherin_2 | PCDHA9 PCDHB6 PCDHB3 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 4.43e-16 | 65 | 210 | 15 | PF08266 |
| Domain | Cadherin_N | PCDHA9 PCDHB6 PCDHB3 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 4.43e-16 | 65 | 210 | 15 | IPR013164 |
| Domain | Cadherin_CS | PCDHA9 PCDHB6 PCDHB3 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.41e-12 | 109 | 210 | 15 | IPR020894 |
| Domain | CADHERIN_1 | PCDHA9 PCDHB6 PCDHB3 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 2.41e-12 | 113 | 210 | 15 | PS00232 |
| Domain | Cadherin | PCDHA9 PCDHB6 PCDHB3 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 2.41e-12 | 113 | 210 | 15 | PF00028 |
| Domain | CADHERIN_2 | PCDHA9 PCDHB6 PCDHB3 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 2.75e-12 | 114 | 210 | 15 | PS50268 |
| Domain | - | PCDHA9 PCDHB6 PCDHB3 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 2.75e-12 | 114 | 210 | 15 | 2.60.40.60 |
| Domain | CA | PCDHA9 PCDHB6 PCDHB3 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 3.13e-12 | 115 | 210 | 15 | SM00112 |
| Domain | Cadherin-like | PCDHA9 PCDHB6 PCDHB3 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 3.56e-12 | 116 | 210 | 15 | IPR015919 |
| Domain | Cadherin | PCDHA9 PCDHB6 PCDHB3 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 4.59e-12 | 118 | 210 | 15 | IPR002126 |
| Domain | Na_channel_asu | 3.09e-06 | 10 | 210 | 4 | IPR001696 | |
| Domain | Na_trans_assoc | 3.09e-06 | 10 | 210 | 4 | IPR010526 | |
| Domain | Na_trans_assoc | 3.09e-06 | 10 | 210 | 4 | PF06512 | |
| Domain | Spectrin | 4.89e-06 | 23 | 210 | 5 | PF00435 | |
| Domain | ACTININ_2 | 4.89e-06 | 23 | 210 | 5 | PS00020 | |
| Domain | ACTININ_1 | 4.89e-06 | 23 | 210 | 5 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 4.89e-06 | 23 | 210 | 5 | IPR001589 | |
| Domain | DUF2012 | 5.56e-06 | 4 | 210 | 3 | PF09430 | |
| Domain | DUF2012 | 5.56e-06 | 4 | 210 | 3 | IPR019008 | |
| Domain | Cys-rich_flank_reg_C | 7.86e-06 | 90 | 210 | 8 | IPR000483 | |
| Domain | LRRCT | 7.86e-06 | 90 | 210 | 8 | SM00082 | |
| Domain | CH | 8.24e-06 | 65 | 210 | 7 | SM00033 | |
| Domain | Leu-rich_rpt | LRRC24 CARMIL3 TLR8 NOD2 SLITRK2 NTRK3 RTN4RL1 LRRC4C LRCH3 LRRC46 RNH1 SLIT3 LRRC15 | 1.27e-05 | 271 | 210 | 13 | IPR001611 |
| Domain | CH | 1.35e-05 | 70 | 210 | 7 | PF00307 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.42e-05 | 14 | 210 | 4 | IPR024317 | |
| Domain | Dynein_HC_stalk | 1.42e-05 | 14 | 210 | 4 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.42e-05 | 14 | 210 | 4 | IPR013602 | |
| Domain | DHC_N2 | 1.42e-05 | 14 | 210 | 4 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 1.42e-05 | 14 | 210 | 4 | IPR011704 | |
| Domain | MT | 1.42e-05 | 14 | 210 | 4 | PF12777 | |
| Domain | AAA_8 | 1.42e-05 | 14 | 210 | 4 | PF12780 | |
| Domain | AAA_5 | 1.42e-05 | 14 | 210 | 4 | PF07728 | |
| Domain | - | 1.49e-05 | 71 | 210 | 7 | 1.10.418.10 | |
| Domain | Spectrin_repeat | 1.63e-05 | 29 | 210 | 5 | IPR002017 | |
| Domain | - | LRRC24 CARMIL3 TLR8 NOD2 SLITRK2 ZYG11A NTRK3 RTN4RL1 LRRC4C LRCH3 LRRC46 RNH1 SLIT3 LRRC15 | 1.72e-05 | 321 | 210 | 14 | 3.80.10.10 |
| Domain | CH | 1.79e-05 | 73 | 210 | 7 | PS50021 | |
| Domain | DHC_fam | 1.92e-05 | 15 | 210 | 4 | IPR026983 | |
| Domain | uDENN | 1.92e-05 | 15 | 210 | 4 | PF03456 | |
| Domain | Dynein_heavy | 1.92e-05 | 15 | 210 | 4 | PF03028 | |
| Domain | Dynein_heavy_dom | 1.92e-05 | 15 | 210 | 4 | IPR004273 | |
| Domain | CH-domain | 2.14e-05 | 75 | 210 | 7 | IPR001715 | |
| Domain | L_dom-like | LRRC24 CARMIL3 TLR8 NOD2 SLITRK2 ZYG11A NTRK3 RTN4RL1 LRRC4C LRCH3 LRRC46 RNH1 SLIT3 LRRC15 | 2.18e-05 | 328 | 210 | 14 | IPR032675 |
| Domain | DENN | 2.54e-05 | 16 | 210 | 4 | SM00799 | |
| Domain | DENN | 2.54e-05 | 16 | 210 | 4 | PF02141 | |
| Domain | dDENN | 2.54e-05 | 16 | 210 | 4 | PF03455 | |
| Domain | UDENN | 2.54e-05 | 16 | 210 | 4 | PS50946 | |
| Domain | DDENN | 2.54e-05 | 16 | 210 | 4 | PS50947 | |
| Domain | dDENN | 2.54e-05 | 16 | 210 | 4 | SM00801 | |
| Domain | dDENN_dom | 2.54e-05 | 16 | 210 | 4 | IPR005112 | |
| Domain | uDENN_dom | 2.54e-05 | 16 | 210 | 4 | IPR005113 | |
| Domain | DENN | 2.54e-05 | 16 | 210 | 4 | PS50211 | |
| Domain | DENN_dom | 2.54e-05 | 16 | 210 | 4 | IPR001194 | |
| Domain | SPEC | 2.69e-05 | 32 | 210 | 5 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 2.69e-05 | 32 | 210 | 5 | IPR018159 | |
| Domain | P-loop_NTPase | ABCA1 MYO5B ABCA13 GIMAP1 MCM6 DDX6 ABCB1 NOD2 IFIH1 NWD2 DLG1 KIFC3 CAMTA1 DNAH8 DNAH9 DYNC1H1 DNAH3 APAF1 ARHGAP5 RAB34 ABCB9 GNA13 SEPTIN10 AFG1L | 3.11e-05 | 848 | 210 | 24 | IPR027417 |
| Domain | LRR_1 | LRRC24 TLR8 SLITRK2 NTRK3 RTN4RL1 LRRC4C LRCH3 LRRC46 RNH1 SLIT3 LRRC15 | 3.93e-05 | 219 | 210 | 11 | PF00560 |
| Domain | Ion_trans_dom | 4.44e-05 | 114 | 210 | 8 | IPR005821 | |
| Domain | Ion_trans | 4.44e-05 | 114 | 210 | 8 | PF00520 | |
| Domain | DHC_N1 | 7.53e-05 | 8 | 210 | 3 | PF08385 | |
| Domain | Carb-bd-like_fold | 7.53e-05 | 8 | 210 | 3 | IPR013784 | |
| Domain | Dynein_heavy_dom-1 | 7.53e-05 | 8 | 210 | 3 | IPR013594 | |
| Domain | LRR | LRRC24 TLR8 NOD2 SLITRK2 NTRK3 RTN4RL1 LRRC4C LRRC46 SLIT3 LRRC15 | 9.56e-05 | 201 | 210 | 10 | PS51450 |
| Domain | - | ABCA1 ABCA13 GIMAP1 MCM6 DDX6 ABCB1 NOD2 IFIH1 NWD2 DLG1 DNAH8 DNAH9 DYNC1H1 DNAH3 APAF1 ARHGAP5 RAB34 ABCB9 GNA13 SEPTIN10 AFG1L | 1.08e-04 | 746 | 210 | 21 | 3.40.50.300 |
| Domain | LRRNT | 1.20e-04 | 98 | 210 | 7 | IPR000372 | |
| Domain | LRRNT | 1.20e-04 | 98 | 210 | 7 | SM00013 | |
| Domain | FAM21 | 1.26e-04 | 2 | 210 | 2 | IPR027308 | |
| Domain | LRR_8 | 1.40e-04 | 171 | 210 | 9 | PF13855 | |
| Domain | ALDOKETO_REDUCTASE_1 | 1.59e-04 | 10 | 210 | 3 | PS00798 | |
| Domain | ALDOKETO_REDUCTASE_2 | 1.59e-04 | 10 | 210 | 3 | PS00062 | |
| Domain | ALDOKETO_REDUCTASE_3 | 1.59e-04 | 10 | 210 | 3 | PS00063 | |
| Domain | Aldo/ket_reductase_CS | 1.59e-04 | 10 | 210 | 3 | IPR018170 | |
| Domain | Aldo/keto_reductase | 1.59e-04 | 10 | 210 | 3 | IPR020471 | |
| Domain | LRR_TYP | LRRC24 TLR8 SLITRK2 RTN4RL1 LRRC4C LRCH3 LRRC46 SLIT3 LRRC15 | 1.82e-04 | 177 | 210 | 9 | SM00369 |
| Domain | Leu-rich_rpt_typical-subtyp | LRRC24 TLR8 SLITRK2 RTN4RL1 LRRC4C LRCH3 LRRC46 SLIT3 LRRC15 | 1.82e-04 | 177 | 210 | 9 | IPR003591 |
| Domain | PKD_channel | 2.16e-04 | 11 | 210 | 3 | PF08016 | |
| Domain | PKD1_2_channel | 2.16e-04 | 11 | 210 | 3 | IPR013122 | |
| Domain | AAA | 2.28e-04 | 144 | 210 | 8 | SM00382 | |
| Domain | AAA+_ATPase | 2.28e-04 | 144 | 210 | 8 | IPR003593 | |
| Domain | LRRNT | 3.17e-04 | 53 | 210 | 5 | PF01462 | |
| Domain | CarboxyPept_regulatory_dom | 3.69e-04 | 13 | 210 | 3 | IPR014766 | |
| Domain | - | 3.69e-04 | 13 | 210 | 3 | 2.60.40.1120 | |
| Domain | TraB | 3.75e-04 | 3 | 210 | 2 | PF01963 | |
| Domain | CAP-ZIP_m | 3.75e-04 | 3 | 210 | 2 | PF15255 | |
| Domain | Pheromone_shutdown_TraB | 3.75e-04 | 3 | 210 | 2 | IPR002816 | |
| Domain | FAM21/CAPZIP | 3.75e-04 | 3 | 210 | 2 | IPR029341 | |
| Domain | uDENN | 4.65e-04 | 14 | 210 | 3 | SM00800 | |
| Domain | IQ_motif_EF-hand-BS | 5.34e-04 | 90 | 210 | 6 | IPR000048 | |
| Domain | IQ | 6.36e-04 | 93 | 210 | 6 | PS50096 | |
| Domain | - | 7.04e-04 | 16 | 210 | 3 | 3.20.20.100 | |
| Domain | DH_1 | 7.09e-04 | 63 | 210 | 5 | PS00741 | |
| Domain | Tscrpt_reg_SKI_SnoN | 7.44e-04 | 4 | 210 | 2 | IPR023216 | |
| Domain | c-SKI_SMAD_bind | 7.44e-04 | 4 | 210 | 2 | PF08782 | |
| Domain | c-SKI_SMAD_bind | 7.44e-04 | 4 | 210 | 2 | SM01046 | |
| Domain | c-SKI_SMAD4-bd_dom | 7.44e-04 | 4 | 210 | 2 | IPR014890 | |
| Domain | NADP_OxRdtase_dom | 8.48e-04 | 17 | 210 | 3 | IPR023210 | |
| Domain | CarboxyPept-like_regulatory | 8.48e-04 | 17 | 210 | 3 | IPR008969 | |
| Domain | Aldo_ket_red | 8.48e-04 | 17 | 210 | 3 | PF00248 | |
| Domain | Aldo/ket_red/Kv-b | 8.48e-04 | 17 | 210 | 3 | IPR001395 | |
| Pathway | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | 1.06e-05 | 52 | 137 | 6 | MM14743 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 1.12e-05 | 31 | 137 | 5 | M877 | |
| Pathway | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | 2.23e-05 | 59 | 137 | 6 | M11215 | |
| Pathway | REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE | 5.94e-05 | 70 | 137 | 6 | MM14824 | |
| Pathway | REACTOME_PREDNISONE_ADME | 6.55e-05 | 23 | 137 | 4 | MM16639 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 7.20e-05 | 45 | 137 | 5 | M47670 | |
| Pathway | WP_BENZOAPYRENE_METABOLISM | 7.23e-05 | 9 | 137 | 3 | M39344 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_KEAP1_NRF2_SIGNALIG_PATHWAY | 7.23e-05 | 9 | 137 | 3 | M47817 | |
| Pathway | REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE | 9.45e-05 | 76 | 137 | 6 | M19832 | |
| Pathway | REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS | 1.02e-04 | 77 | 137 | 6 | MM15044 | |
| Pathway | REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS | 1.26e-04 | 80 | 137 | 6 | M800 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 1.26e-04 | 27 | 137 | 4 | M47755 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_BENZO_A_PYRENRE_TO_CYP_MEDIATED_METABOLISM | 1.40e-04 | 11 | 137 | 3 | M47812 | |
| Pathway | REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING | 1.76e-04 | 85 | 137 | 6 | MM14746 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | 2.39e-04 | 13 | 137 | 3 | M17842 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | 2.39e-04 | 13 | 137 | 3 | MM14747 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 2.49e-04 | 32 | 137 | 4 | M27455 | |
| Pathway | WP_GLUCOCORTICOID_BIOSYNTHESIS | 3.02e-04 | 14 | 137 | 3 | M46449 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 3.02e-04 | 14 | 137 | 3 | M27074 | |
| Pathway | WP_MINERALOCORTICOID_BIOSYNTHESIS | 3.02e-04 | 14 | 137 | 3 | M46453 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 3.02e-04 | 14 | 137 | 3 | MM14748 | |
| Pathway | REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING | 3.61e-04 | 97 | 137 | 6 | M9400 | |
| Pathway | REACTOME_SYNTHESIS_OF_PROSTAGLANDINS_PG_AND_THROMBOXANES_TX | 3.75e-04 | 15 | 137 | 3 | MM14870 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 4.80e-04 | 67 | 137 | 5 | MM15327 | |
| Pathway | REACTOME_METABOLISM_OF_STEROIDS | 7.62e-04 | 154 | 137 | 7 | M27832 | |
| Pathway | BIOCARTA_LIS1_PATHWAY | 7.76e-04 | 19 | 137 | 3 | M22005 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 7.85e-04 | 43 | 137 | 4 | M47669 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 8.57e-04 | 44 | 137 | 4 | M11911 | |
| Pathway | WP_LUNG_PATHOLOGY_OF_COVID19 | 9.07e-04 | 20 | 137 | 3 | M48333 | |
| Pathway | BIOCARTA_NKCELLS_PATHWAY | 9.07e-04 | 20 | 137 | 3 | M16355 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RORA_MEDIATED_TRANSCRIPTION | 9.20e-04 | 5 | 137 | 2 | M49011 | |
| Pathway | WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION | 9.34e-04 | 45 | 137 | 4 | M39355 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 9.34e-04 | 45 | 137 | 4 | MM15344 | |
| Pathway | PID_RHOA_REG_PATHWAY | 1.02e-03 | 46 | 137 | 4 | M68 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 1.16e-03 | 121 | 137 | 6 | M872 | |
| Pubmed | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.15e-27 | 15 | 212 | 13 | 15640798 | |
| Pubmed | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 2.57e-26 | 17 | 212 | 13 | 29911975 | |
| Pubmed | CNR/Pcdhalpha family in subplate neurons, and developing cortical connectivity. | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 9.22e-26 | 18 | 212 | 13 | 15570159 |
| Pubmed | Genomic organization of the family of CNR cadherin genes in mice and humans. | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 9.22e-26 | 18 | 212 | 13 | 10662547 |
| Pubmed | PCDHA9 PCDHB3 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.18e-25 | 24 | 212 | 14 | 24698270 | |
| Pubmed | Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha. | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 3.82e-22 | 28 | 212 | 13 | 15347688 |
| Pubmed | Diversity revealed by a novel family of cadherins expressed in neurons at a synaptic complex. | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 | 6.26e-22 | 11 | 212 | 10 | 9655502 |
| Pubmed | Clustered gamma-protocadherins regulate cortical interneuron programmed cell death. | PCDHA9 PCDHB6 PCDHB3 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 6.35e-21 | 57 | 212 | 15 | 32633719 |
| Pubmed | CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons. | PCDHA9 PCDHB6 PCDHB3 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 8.52e-21 | 58 | 212 | 15 | 30377227 |
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | PCDHA9 PCDHB6 PCDHB3 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.20e-19 | 68 | 212 | 15 | 11230163 |
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | PCDHA9 PCDHB6 PCDHB3 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 3.07e-19 | 72 | 212 | 15 | 10380929 |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | PCDHA9 PCDHB6 PCDHB3 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 4.80e-19 | 74 | 212 | 15 | 10817752 |
| Pubmed | PCDHA9 PCDHB6 PCDHB3 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 9.13e-19 | 77 | 212 | 15 | 10835267 | |
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | PCDHA9 PCDHB6 PCDHB3 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.69e-18 | 80 | 212 | 15 | 10716726 |
| Pubmed | Proteins of the CNR family are multiple receptors for Reelin. | 8.09e-16 | 12 | 212 | 8 | 10612399 | |
| Pubmed | The DNA sequence and comparative analysis of human chromosome 5. | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.00e-15 | 75 | 212 | 13 | 15372022 |
| Pubmed | A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220. | PCDHA9 C8orf74 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 2.14e-14 | 119 | 212 | 14 | 28625976 |
| Pubmed | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 2.32e-10 | 193 | 212 | 13 | 22589738 | |
| Pubmed | 6.68e-09 | 5 | 212 | 4 | 34888534 | ||
| Pubmed | PCDHA9 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 NBEA PCDHA3 PCDHA2 PCDHA1 SUV39H2 SOS2 | 1.78e-08 | 329 | 212 | 14 | 17474147 | |
| Pubmed | VPS13C ADGRV1 DDX6 SYNE1 NUP214 DENND3 HMCN1 FANCI MACF1 HTT | 3.62e-08 | 152 | 212 | 10 | 34299191 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | VPS13C INTS1 COQ8B ADGRB1 RPS6KC1 ESRP2 DST TRPM3 SCN8A PKHD1 ALOX5 DYNC1H1 DNAH3 GPAM PCDHA5 NBEA ARHGAP5 RNF123 POTEA | 1.54e-07 | 736 | 212 | 19 | 29676528 |
| Pubmed | 1.65e-07 | 9 | 212 | 4 | 16382098 | ||
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | DLG1 DYNC1H1 KALRN ANXA2P2 SYNE1 NTRK3 ARHGEF18 NBEA GRM1 GRM3 GNA13 MACF1 | 1.83e-07 | 281 | 212 | 12 | 28706196 |
| Pubmed | 2.23e-07 | 3 | 212 | 3 | 19320734 | ||
| Pubmed | 2.23e-07 | 3 | 212 | 3 | 21232532 | ||
| Pubmed | Aldo-keto reductases protect metastatic melanoma from ER stress-independent ferroptosis. | 2.23e-07 | 3 | 212 | 3 | 31780644 | |
| Pubmed | 2.23e-07 | 3 | 212 | 3 | 13678667 | ||
| Pubmed | 2.23e-07 | 3 | 212 | 3 | 36011023 | ||
| Pubmed | Identification of two novel PCDHA9 mutations associated with Hirschsprung's disease. | 2.23e-07 | 3 | 212 | 3 | 29477871 | |
| Pubmed | Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes. | 2.23e-07 | 3 | 212 | 3 | 25576386 | |
| Pubmed | TPR GPRASP1 HDAC4 LRRC24 FYCO1 DST NGEF DLG1 GOLGA1 DYNC1H1 GOLGB1 FERMT3 KALRN SYNE1 ARHGEF18 NBEA GRM1 GRM3 MACF1 ATP2B4 LRRC15 | 5.36e-07 | 963 | 212 | 21 | 28671696 | |
| Pubmed | 8.89e-07 | 4 | 212 | 3 | 10393440 | ||
| Pubmed | Mouse Akr1cl gene product is a prostaglandin D2 11-ketoreductase with strict substrate specificity. | 8.89e-07 | 4 | 212 | 3 | 31479646 | |
| Pubmed | 8.89e-07 | 4 | 212 | 3 | 10702227 | ||
| Pubmed | 8.89e-07 | 4 | 212 | 3 | 17442338 | ||
| Pubmed | 8.89e-07 | 4 | 212 | 3 | 28329705 | ||
| Pubmed | 8.89e-07 | 4 | 212 | 3 | 16511129 | ||
| Pubmed | 8.89e-07 | 4 | 212 | 3 | 15222881 | ||
| Pubmed | Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology. | 8.89e-07 | 4 | 212 | 3 | 31833031 | |
| Pubmed | 8.89e-07 | 4 | 212 | 3 | 10526179 | ||
| Pubmed | 8.89e-07 | 4 | 212 | 3 | 21521174 | ||
| Pubmed | 8.89e-07 | 4 | 212 | 3 | 8274401 | ||
| Pubmed | 8.89e-07 | 4 | 212 | 3 | 10803568 | ||
| Pubmed | AKR1C1 alleviates LPS‑induced ALI in mice by activating the JAK2/STAT3 signaling pathway. | 8.89e-07 | 4 | 212 | 3 | 34590152 | |
| Pubmed | 8.89e-07 | 4 | 212 | 3 | 9267806 | ||
| Pubmed | Structure and activity of the murine type 5 17beta-hydroxysteroid dehydrogenase gene(1). | 8.89e-07 | 4 | 212 | 3 | 10500239 | |
| Pubmed | 8.89e-07 | 4 | 212 | 3 | 19487289 | ||
| Pubmed | Cloning and chromosomal localization of mouse 20alpha-hydroxysteroid dehydrogenase gene. | 8.89e-07 | 4 | 212 | 3 | 14967952 | |
| Pubmed | Localization of 20alpha-hydroxysteroid dehydrogenase mRNA in mouse brain by in situ hybridization. | 8.89e-07 | 4 | 212 | 3 | 15193432 | |
| Pubmed | 8.89e-07 | 4 | 212 | 3 | 16191478 | ||
| Pubmed | 8.89e-07 | 4 | 212 | 3 | 15577209 | ||
| Pubmed | 8.89e-07 | 4 | 212 | 3 | 17034817 | ||
| Pubmed | RECON-Dependent Inflammation in Hepatocytes Enhances Listeria monocytogenes Cell-to-Cell Spread. | 8.89e-07 | 4 | 212 | 3 | 29764944 | |
| Pubmed | 8.89e-07 | 4 | 212 | 3 | 17888864 | ||
| Pubmed | 8.89e-07 | 4 | 212 | 3 | 19237748 | ||
| Pubmed | 8.89e-07 | 4 | 212 | 3 | 28259989 | ||
| Pubmed | 8.89e-07 | 4 | 212 | 3 | 7789999 | ||
| Pubmed | 8.89e-07 | 4 | 212 | 3 | 20124700 | ||
| Pubmed | Enzymatic properties of a member (AKR1C20) of the aldo-keto reductase family. | 8.89e-07 | 4 | 212 | 3 | 16508162 | |
| Pubmed | 8.89e-07 | 4 | 212 | 3 | 17629694 | ||
| Pubmed | 8.89e-07 | 4 | 212 | 3 | 16018803 | ||
| Pubmed | 8.89e-07 | 4 | 212 | 3 | 17272929 | ||
| Pubmed | Involvement of 20alpha-hydroxysteroid dehydrogenase in the maintenance of pregnancy in mice. | 8.89e-07 | 4 | 212 | 3 | 18667791 | |
| Pubmed | WASHC2A SNX13 MLC1 KATNIP CAMTA1 DYNC1H1 WASHC2C SYNE1 NUP214 LRRC4C DENND11 USP8 MACF1 | 1.51e-06 | 407 | 212 | 13 | 12693553 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | HDAC4 CARMIL3 WASHC2A ITPR1 RPS6KC1 NWD2 A2ML1 SCN8A NGEF WASHC2C KALRN NUP214 ARHGAP5 HTT | 1.52e-06 | 475 | 212 | 14 | 31040226 |
| Pubmed | Epigenetic functions of smchd1 repress gene clusters on the inactive X chromosome and on autosomes. | 1.64e-06 | 59 | 212 | 6 | 23754746 | |
| Pubmed | 2.21e-06 | 5 | 212 | 3 | 15212687 | ||
| Pubmed | 2.21e-06 | 5 | 212 | 3 | 7737980 | ||
| Pubmed | 2.21e-06 | 5 | 212 | 3 | 17724025 | ||
| Pubmed | 2.21e-06 | 5 | 212 | 3 | 38788959 | ||
| Pubmed | 2.21e-06 | 5 | 212 | 3 | 18003893 | ||
| Pubmed | Retinaldehyde is a substrate for human aldo-keto reductases of the 1C subfamily. | 2.21e-06 | 5 | 212 | 3 | 21851338 | |
| Pubmed | Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis. | 2.21e-06 | 5 | 212 | 3 | 16984997 | |
| Pubmed | 2.21e-06 | 5 | 212 | 3 | 17872381 | ||
| Pubmed | Mouse 3alpha-hydroxysteroid dehydrogenase mRNA: a marker of lung maturity. | 2.21e-06 | 5 | 212 | 3 | 17064890 | |
| Pubmed | 2.21e-06 | 5 | 212 | 3 | 10672042 | ||
| Pubmed | Activation of Rac GTPase by p75 is necessary for c-jun N-terminal kinase-mediated apoptosis. | 3.42e-06 | 38 | 212 | 5 | 11756498 | |
| Pubmed | TPR STARD8 DEF8 WASHC2A AKR1C1 AKR1C2 ITPR1 RPS6KC1 INTS2 DLG1 CAMTA1 GOLGB1 KLHL6 FAM234B WASHC2C ARHGEF18 APOB ARHGAP5 SBF2 AKR1C3 MACF1 | 3.46e-06 | 1084 | 212 | 21 | 11544199 | |
| Pubmed | 4.41e-06 | 6 | 212 | 3 | 19273550 | ||
| Pubmed | 4.41e-06 | 6 | 212 | 3 | 15471942 | ||
| Pubmed | MEF2 and NR2F2 cooperate to regulate Akr1c14 gene expression in mouse MA-10 Leydig cells. | 4.41e-06 | 6 | 212 | 3 | 26748576 | |
| Pubmed | 4.41e-06 | 6 | 212 | 3 | 17122075 | ||
| Pubmed | The Gαq/11-provoked induction of Akr1c18 in murine luteal cells is mediated by phospholipase C. | 4.41e-06 | 6 | 212 | 3 | 29107092 | |
| Pubmed | 4.41e-06 | 6 | 212 | 3 | 15860270 | ||
| Pubmed | Decidual prolactin silences the expression of genes detrimental to pregnancy. | 4.41e-06 | 6 | 212 | 3 | 17255200 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | HDAC4 VPS13C ADGRV1 CCNY INTS2 TGFBRAP1 NGEF EXOC6B KCNN2 DLG1 KATNIP CAB39L DENND5A CAMTA1 GOLGB1 ARHGEF18 RTN4RL1 SKI LRCH3 FOXP4 SBF2 KNDC1 MACF1 HTT SOS2 | 4.91e-06 | 1489 | 212 | 25 | 28611215 |
| Pubmed | 6.40e-06 | 43 | 212 | 5 | 12376548 | ||
| Pubmed | 7.18e-06 | 44 | 212 | 5 | 19322198 | ||
| Pubmed | 7.68e-06 | 7 | 212 | 3 | 33127481 | ||
| Pubmed | 7.68e-06 | 7 | 212 | 3 | 12562828 | ||
| Pubmed | 7.68e-06 | 7 | 212 | 3 | 19846565 | ||
| Pubmed | 7.68e-06 | 7 | 212 | 3 | 22529366 | ||
| Pubmed | 7.68e-06 | 7 | 212 | 3 | 26160177 | ||
| Pubmed | Aldo-ketoreductase 1c19 ablation does not affect insulin secretion in murine islets. | 7.68e-06 | 7 | 212 | 3 | 34843575 | |
| Pubmed | 7.68e-06 | 7 | 212 | 3 | 16337335 | ||
| Pubmed | 7.72e-06 | 163 | 212 | 8 | 16512683 | ||
| Pubmed | EFCAB5 MYO5B TTC16 GPR101 ABCB1 RPS6KC1 NRXN3 DST SCN4A PKHD1 DLG1 METTL25 DNAH8 GOLGB1 SYNE1 RRP15 APOB SKI USP8 STS ABCB9 GNA13 MACF1 SEPTIN10 | 8.90e-06 | 1442 | 212 | 24 | 35575683 | |
| Pubmed | 1.22e-05 | 8 | 212 | 3 | 20837989 | ||
| Pubmed | 1.22e-05 | 8 | 212 | 3 | 33584538 | ||
| Interaction | PCDHA10 interactions | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 | 5.91e-19 | 22 | 207 | 12 | int:PCDHA10 |
| Interaction | PCDHA8 interactions | PCDHA13 PCDHA12 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 ABCB9 | 8.29e-12 | 55 | 207 | 11 | int:PCDHA8 |
| Interaction | PCDHA7 interactions | 3.52e-11 | 14 | 207 | 7 | int:PCDHA7 | |
| Interaction | PCDHA11 interactions | 4.95e-10 | 19 | 207 | 7 | int:PCDHA11 | |
| Interaction | PCDHA3 interactions | 1.56e-09 | 34 | 207 | 8 | int:PCDHA3 | |
| Interaction | PCDHA1 interactions | 1.33e-08 | 9 | 207 | 5 | int:PCDHA1 | |
| Interaction | PCDHGA10 interactions | 2.65e-08 | 19 | 207 | 6 | int:PCDHGA10 | |
| Interaction | FLT3 interactions | PCDHA9 DYNC1H1 C8orf74 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 APOB PCDHA1 FANCI | 3.43e-08 | 318 | 207 | 17 | int:FLT3 |
| Interaction | PCDHA4 interactions | 1.75e-07 | 60 | 207 | 8 | int:PCDHA4 | |
| Interaction | PCDHA9 interactions | 7.92e-07 | 32 | 207 | 6 | int:PCDHA9 | |
| Interaction | PCDHA6 interactions | 1.31e-06 | 9 | 207 | 4 | int:PCDHA6 | |
| Interaction | SCN8A interactions | 1.49e-06 | 20 | 207 | 5 | int:SCN8A | |
| Interaction | DSCAM interactions | GPRASP1 DST NOMO2 DLG1 KIFC3 DYNC1H1 KALRN SYNE1 SKIL MACF1 SOS2 | 1.62e-06 | 171 | 207 | 11 | int:DSCAM |
| Interaction | PCDHA5 interactions | 4.24e-06 | 4 | 207 | 3 | int:PCDHA5 | |
| Interaction | PCDHA12 interactions | 7.26e-06 | 46 | 207 | 6 | int:PCDHA12 | |
| Interaction | PCDHA2 interactions | 9.98e-06 | 14 | 207 | 4 | int:PCDHA2 | |
| Interaction | MLYCD interactions | 1.26e-05 | 30 | 207 | 5 | int:MLYCD | |
| Interaction | DLG2 interactions | 2.34e-05 | 83 | 207 | 7 | int:DLG2 | |
| Interaction | PCDHA13 interactions | 3.63e-05 | 7 | 207 | 3 | int:PCDHA13 | |
| Interaction | CAPZA2 interactions | MYO5B WASHC2A CALHM4 ITPR1 DST EXOC6B PLS3 WASHC2C LRCH3 TGM3 MACF1 CAPZA3 LRRC15 HTT DCTN3 | 4.07e-05 | 430 | 207 | 15 | int:CAPZA2 |
| Interaction | LONP2 interactions | 4.16e-05 | 62 | 207 | 6 | int:LONP2 | |
| Interaction | AKR1C1 interactions | 4.60e-05 | 20 | 207 | 4 | int:AKR1C1 | |
| Interaction | DTNBP1 interactions | 4.66e-05 | 162 | 207 | 9 | int:DTNBP1 | |
| Interaction | AKR1C4 interactions | 5.76e-05 | 8 | 207 | 3 | int:AKR1C4 | |
| Interaction | AGAP2 interactions | DLG1 DYNC1H1 KALRN SYNE1 ARHGEF18 NBEA GRM1 GRM3 GNA13 MACF1 | 6.55e-05 | 210 | 207 | 10 | int:AGAP2 |
| Cytoband | 5q31 | PCDHA9 PCDHB6 PCDHB3 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 8.95e-18 | 115 | 212 | 15 | 5q31 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | PCDHA9 TMCO6 PCDHB6 PCDHB3 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 9.45e-13 | 298 | 212 | 16 | chr5q31 |
| Cytoband | 10p15-p14 | 1.92e-06 | 6 | 212 | 3 | 10p15-p14 | |
| Cytoband | 7p12.3 | 1.40e-04 | 22 | 212 | 3 | 7p12.3 | |
| Cytoband | 3q29 | 6.11e-04 | 83 | 212 | 4 | 3q29 | |
| GeneFamily | Clustered protocadherins | PCDHA9 PCDHB6 PCDHB3 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 3.02e-18 | 64 | 149 | 15 | 20 |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 5.41e-07 | 9 | 149 | 4 | 1203 | |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 4.90e-05 | 25 | 149 | 4 | 504 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.12e-04 | 66 | 149 | 5 | 722 | |
| GeneFamily | Aldo-keto reductases | 2.32e-04 | 15 | 149 | 3 | 399 | |
| GeneFamily | Dyneins, axonemal | 3.43e-04 | 17 | 149 | 3 | 536 | |
| GeneFamily | SKI transcriptional corepressors | 4.00e-04 | 4 | 149 | 2 | 748 | |
| GeneFamily | WASH complex | 9.90e-04 | 6 | 149 | 2 | 1331 | |
| GeneFamily | Transient receptor potential cation channels | 1.54e-03 | 28 | 149 | 3 | 249 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.83e-03 | 8 | 149 | 2 | 939 | |
| GeneFamily | Glutamate metabotropic receptors|Protein phosphatase 1 regulatory subunits | 1.83e-03 | 8 | 149 | 2 | 281 | |
| GeneFamily | WD repeat domain containing|Caspase recruitment domain containing|Apoptosome | 1.89e-03 | 30 | 149 | 3 | 959 | |
| GeneFamily | ATP binding cassette subfamily B | 3.53e-03 | 11 | 149 | 2 | 806 | |
| GeneFamily | ATP binding cassette subfamily A | 5.75e-03 | 14 | 149 | 2 | 805 | |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED | PCDHA9 GPR101 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 SLC2A5 | 3.96e-09 | 261 | 212 | 15 | MM1277 |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED | PCDHA9 GPR101 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 SLC2A5 | 9.87e-09 | 238 | 212 | 14 | M2020 |
| Coexpression | GSE30083_SP2_VS_SP3_THYMOCYTE_UP | CARMIL3 PTGER3 TC2N FAR1 PCDHB6 PCDHB3 SLC15A1 AKR1C3 C1QTNF12 MCOLN3 | 5.48e-06 | 199 | 212 | 10 | M5031 |
| Coexpression | GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN | 8.84e-06 | 166 | 212 | 9 | M6826 | |
| Coexpression | LAKE_ADULT_KIDNEY_C15_CONNECTING_TUBULE | 1.12e-05 | 171 | 212 | 9 | M39234 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA13 ADGRV1 SLITRK2 TRPM3 PKHD1 DNAH9 KALRN APOB LRRC4C GRM1 HMCN1 | 1.45e-09 | 184 | 212 | 11 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA13 ADGRV1 SLITRK2 TRPM3 PKHD1 DNAH9 KALRN APOB LRRC4C GRM1 HMCN1 | 1.45e-09 | 184 | 212 | 11 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA13 ADGRV1 SLITRK2 TRPM3 PKHD1 DNAH9 KALRN APOB LRRC4C GRM1 HMCN1 | 1.45e-09 | 184 | 212 | 11 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA1 CARMIL3 VPS13C DST SCAPER DYNC1H1 GOLGB1 ERO1B NBEA MACF1 | 3.54e-08 | 195 | 212 | 10 | 7796ea9247f4c63762f0de8490fed08b9717fa23 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA1 CARMIL3 VPS13C DST SCAPER DYNC1H1 GOLGB1 ERO1B NBEA MACF1 | 3.54e-08 | 195 | 212 | 10 | 3e519cffa6144a62b06124642a14c9ff39b76554 |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | EPHB3 MYO5B NRXN3 TRPM3 PKHD1 KIFC3 GOLGB1 NDNF DENND3 AKR1C3 | 4.09e-08 | 198 | 212 | 10 | 85f424cd9bb3117c9e322031024aabb87696ce47 |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.50e-08 | 200 | 212 | 10 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | EPHB3 MYO5B VPS13C NRXN3 TRPM3 PKHD1 KIFC3 GOLGB1 NDNF FOXP4 | 4.50e-08 | 200 | 212 | 10 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.84e-07 | 186 | 212 | 9 | 84ba666237c18189d7e7556bd92dd953af733c00 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.60e-07 | 197 | 212 | 9 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.01e-07 | 199 | 212 | 9 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.01e-07 | 199 | 212 | 9 | a270630626df614f8605abddb7dee7c4d74f6149 | |
| ToppCell | Neuronal-Excitatory|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.22e-07 | 200 | 212 | 9 | 4409065bc7aa995354c71e0f9d6f3726cf393d6b | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.70e-07 | 148 | 212 | 8 | c240d506151fa90c59f40008c5fb31984c6f6f8f | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_VISp_Adamts2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.49e-07 | 156 | 212 | 8 | 2cd007b423c2395c5ce331902e7f27c805755eb3 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.13e-06 | 162 | 212 | 8 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-2|ILC / Donor, Lineage, Cell class and subclass (all cells) | 1.77e-06 | 172 | 212 | 8 | 4977e1f4deae781750e27a8054deccd336cfb74a | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.19e-06 | 177 | 212 | 8 | 84591e28482ab62a5ef41e61043eb64912766356 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.19e-06 | 177 | 212 | 8 | 4bc100062891d07cacd10ffba38966cc6302c92f | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.19e-06 | 177 | 212 | 8 | 9f3a2adb9cd4f0a059afc87b6e377a9702154bb1 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.19e-06 | 177 | 212 | 8 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.38e-06 | 179 | 212 | 8 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.17e-06 | 186 | 212 | 8 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2.Synpr-Nnat_(Neuron.Gad1Gad2.Synpr-Nnat)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.27e-06 | 85 | 212 | 6 | 642755ed2b562dd5e599a04a2b9730e8d29aefe8 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2.Synpr-Nnat_(Neuron.Gad1Gad2.Synpr-Nnat)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.27e-06 | 85 | 212 | 6 | 2429bacccd103e5b2414264b4aff3103ed9d7cec | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.30e-06 | 187 | 212 | 8 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.57e-06 | 189 | 212 | 8 | a75226616340045b581d08429d2e123e041dee55 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.33e-06 | 194 | 212 | 8 | 24837a27b0041fe8c348225fa8b09b127d743603 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Neuronal-Glial_mature-Adult_Glia|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.33e-06 | 194 | 212 | 8 | d429bb5e422a07bd92f0dc48cd51528e8b7d9a72 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Neuronal-Glial_mature|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.33e-06 | 194 | 212 | 8 | 408dfc7060095972a54ae37ae8105521df6fbbee | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Neuronal|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.33e-06 | 194 | 212 | 8 | bffdf6db0bf3fb338e7bb0789ae7dcde1fce0094 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.49e-06 | 195 | 212 | 8 | a1478021a3ed0e779716393124ca2a7770c433b7 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-06 | 196 | 212 | 8 | 90edf61116ffcb4f8b6be3d0a05732d59b0a87d5 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-06 | 196 | 212 | 8 | c936014125b2ed5f796221b74acb77b8f8359875 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.84e-06 | 197 | 212 | 8 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.03e-06 | 198 | 212 | 8 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.22e-06 | 199 | 212 | 8 | 121de4e02585de3a3010398387c523bacf8ce546 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.41e-06 | 200 | 212 | 8 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal-Interneuron|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 5.41e-06 | 200 | 212 | 8 | a6500d0d2e8bcac92381ab771dbdee66b0e1d48e | |
| ToppCell | Control-Plasmablast|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 6.22e-06 | 145 | 212 | 7 | fe68582f5a15b9714cb84fa32ac880e13cb69895 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.39e-05 | 164 | 212 | 7 | 57301178e420983c0cb72178e288a3a0449fdda3 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.62e-05 | 168 | 212 | 7 | af82e07d1eec51fc6530155f37addbce6221885d | |
| ToppCell | ileum|World / shred on tissue and cell subclass | 1.75e-05 | 170 | 212 | 7 | 9f1211bd4287620e19a59f21e6ecdca3e42e0260 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.96e-05 | 173 | 212 | 7 | c3762655caa79ac4879876f470d32578a3c93b01 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.04e-05 | 174 | 212 | 7 | 41eb0a214a8b4015a26311f77061c8147144f0e7 | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-05 | 175 | 212 | 7 | 5552ff1e13f931c8cd7780726c90b5609497a648 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-05 | 176 | 212 | 7 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.19e-05 | 176 | 212 | 7 | c7be4eaa5eb76ad9389fb9d15ad0934e88d267d1 | |
| ToppCell | facs-GAT-Fat-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-05 | 176 | 212 | 7 | acd05ca8952710feedbfe377b1330f3c2406d044 | |
| ToppCell | (01)_Cycling_Basal_(homeostasis)-(1)_24hpi|(01)_Cycling_Basal_(homeostasis) / shred by cell type and Timepoint | 2.24e-05 | 71 | 212 | 5 | 6aa56b0daaeb5e0ae30619f9c6945c8e42899b27 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.27e-05 | 177 | 212 | 7 | d05497d2c80a66ec6a4e1733fea3a5534877a6a7 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.27e-05 | 177 | 212 | 7 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.27e-05 | 177 | 212 | 7 | 8b003ed7887479c3a010ef37dd981b748256bda7 | |
| ToppCell | Control-Epithelial_alveolar-AT_1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.36e-05 | 178 | 212 | 7 | aa7d43c655df493f1330a5001efaa484e4a19f69 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-05 | 178 | 212 | 7 | de6cd81e6d58e7687386df163471bf1901b9c0aa | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.44e-05 | 179 | 212 | 7 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | COVID-19-kidney-tDL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.53e-05 | 180 | 212 | 7 | 864c895b5eaedefae86f5829fa344f7b686fb59f | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.62e-05 | 181 | 212 | 7 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | COVID-19-kidney-Stressed_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.62e-05 | 181 | 212 | 7 | 6980ea624151da32b7f537f263e40fcb87a02e81 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-AT1-AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.72e-05 | 182 | 212 | 7 | cc79e0cc21e2fdc4ef77f052818d27b9f707aec1 | |
| ToppCell | COVID-19_Mild-CD4+_T_activated|COVID-19_Mild / Disease condition and Cell class | 2.72e-05 | 182 | 212 | 7 | 877b6e611626628e709568747512f2827ebb2795 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.81e-05 | 183 | 212 | 7 | 274483009b309289e4cb84beedf6806430db6ff6 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.91e-05 | 184 | 212 | 7 | cdf6f1c6cce97a7effa0c55959652e2c0b6992b3 | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_Erythro-Mega-Mega-Mast|bone_marrow / Manually curated celltypes from each tissue | 2.91e-05 | 184 | 212 | 7 | 030d5ef5e44e4d973862128fe01f7e8ef0092a06 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT1-AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.02e-05 | 185 | 212 | 7 | 3bef59cc0aa939d2a7e52f0f6c61bc00528fe50b | |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|World / Disease state, Lineage and Cell class | 3.02e-05 | 185 | 212 | 7 | 85cb81759589a26d83676cffbf2bc37399683c10 | |
| ToppCell | Control-Epithelial_alveolar|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.02e-05 | 185 | 212 | 7 | 3937e026add96a396122139daf8011cfbc60e75c | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.02e-05 | 185 | 212 | 7 | c82eab551f65ecebe6db908eda9f9eb3414693c7 | |
| ToppCell | pdx-Tumor_cells-T0|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.02e-05 | 185 | 212 | 7 | 1d874608aa2062024323512f68889219471b2f00 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.12e-05 | 186 | 212 | 7 | 56c139e679d640ea901ead657a8e8887e0fca098 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.12e-05 | 186 | 212 | 7 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.12e-05 | 186 | 212 | 7 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.23e-05 | 187 | 212 | 7 | ff26a533d310126521efe1d05cf8b9d32e524550 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.58e-05 | 190 | 212 | 7 | b855b8b7d3439023390ca44629c1a99f5d4c6801 | |
| ToppCell | facs-Kidney-nan-3m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.58e-05 | 190 | 212 | 7 | 68ba1934b2b3f0cec8efd229fe1db6e8be8a26b0 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.58e-05 | 190 | 212 | 7 | d594da827e3c16644952b9589cc12b947ce36279 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 3.58e-05 | 190 | 212 | 7 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | facs-Kidney-nan-3m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.58e-05 | 190 | 212 | 7 | 010d7d13a3c16e614c36720ef690a505b9f3f7aa | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.70e-05 | 191 | 212 | 7 | 72dbd2e0fabfca8d6f604df35277d3574739a0b3 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.70e-05 | 191 | 212 | 7 | fd345837bfc40d85256b9a7e4fd3343bcbfe0ae5 | |
| ToppCell | Control-Plasmablast|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.70e-05 | 191 | 212 | 7 | 3df5bbdb29bbcbcb8476fdf126b6d4c1ac67d64b | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 3.82e-05 | 192 | 212 | 7 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.82e-05 | 192 | 212 | 7 | 261211a86e6f63b09c2ddce1d2d9257d311f1770 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.95e-05 | 193 | 212 | 7 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.08e-05 | 194 | 212 | 7 | 88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.08e-05 | 194 | 212 | 7 | a71728202493d4858342ea2756ea281cd0d99a3a | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.22e-05 | 195 | 212 | 7 | a71ba5e4043e2d35a45a2c60a96b087e31832345 | |
| ToppCell | Macrophages-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 4.22e-05 | 195 | 212 | 7 | 2af46e87947c16a7c2c367637e606cfbb8a78528 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.50e-05 | 197 | 212 | 7 | 32b770e403028862f91e4727f4a8fbb6151910e4 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-monocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.50e-05 | 197 | 212 | 7 | b2f4d7c301c0b24003374923b31d6d058e40b213 | |
| ToppCell | ASK440-Epithelial-Type_1|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.50e-05 | 197 | 212 | 7 | 782449c522c9e16e72bf999a73090688a3aefe06 | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.62e-05 | 135 | 212 | 6 | b7a792a7c0c22d8b703509f134115f0e394d7de0 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.64e-05 | 198 | 212 | 7 | a1b310274aa9b3d2aa1fe9488d67422bf4ac81d2 | |
| ToppCell | mild_COVID-19_(asymptomatic)-NK|World / disease group, cell group and cell class (v2) | 4.64e-05 | 198 | 212 | 7 | 7a0aac52d785037455e068e1b25de4b2bf0fff79 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.64e-05 | 198 | 212 | 7 | a781fd35a7cda8b7760c2e3ddccaac7aac26c979 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.64e-05 | 198 | 212 | 7 | df399674345c45738d765a8354ea8d1484572c34 | |
| ToppCell | healthy_donor-Lymphocytic-ILC-NK_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 4.64e-05 | 198 | 212 | 7 | d7053a898e04478c577381085f615edaad3cdc5b | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.64e-05 | 198 | 212 | 7 | 36c97eb71b89bac01cabd6a8b728e5a20e52d2a3 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.64e-05 | 198 | 212 | 7 | 76aff381403bc5a8a9cc73eb1e5dbdc0bac7de6c | |
| ToppCell | healthy_donor-Lymphocytic-ILC|healthy_donor / Disease condition, Lineage, Cell class and subclass | 4.64e-05 | 198 | 212 | 7 | aa33be29e26f1b8facfc894413099083ae3bbb1b | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.49e-04 | 49 | 112 | 5 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.64e-04 | 50 | 112 | 5 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4 | |
| Drug | Chelidonine monohydrate (+) [476-32-4]; Up 200; 10.8uM; MCF7; HT_HG-U133A | TLR8 SPTBN5 CLCA1 SCN10A KALRN GRM1 SLC1A4 TG TGM3 SLC15A1 ATP2B4 LRRC15 | 2.99e-07 | 197 | 209 | 12 | 2779_UP |
| Drug | cyclopentanol | 7.63e-07 | 3 | 209 | 3 | ctd:C016327 | |
| Drug | cyclopentanone | 7.63e-07 | 3 | 209 | 3 | ctd:C007201 | |
| Drug | 4-benzoylbenzoic acid | 7.63e-07 | 3 | 209 | 3 | ctd:C058818 | |
| Drug | dichloro(4-cymene)ruthenium(II) | 7.63e-07 | 3 | 209 | 3 | ctd:C530610 | |
| Drug | Bupivacaine hydrochloride [18010-40-7]; Up 200; 12.4uM; PC3; HT_HG-U133A | PLXND1 PTGER3 ITIH2 NRXN3 MLC1 APAF1 SLC1A4 TG STS B3GAT1 LRRC15 | 2.10e-06 | 196 | 209 | 11 | 5112_UP |
| Drug | cloxazolam | 3.03e-06 | 4 | 209 | 3 | ctd:C005522 | |
| Drug | Pregnanes | 3.03e-06 | 4 | 209 | 3 | ctd:D011278 | |
| Drug | tetralol | 3.03e-06 | 4 | 209 | 3 | ctd:C019106 | |
| Drug | gliquidone | 3.03e-06 | 4 | 209 | 3 | ctd:C010969 | |
| Drug | 3',3'',5',5''-tetrabromophenolphthalein | 3.03e-06 | 4 | 209 | 3 | ctd:C018156 | |
| Drug | Meclofenamic Acid | 6.43e-06 | 14 | 209 | 4 | ctd:D008469 | |
| Drug | Hydroxysteroids | 7.52e-06 | 5 | 209 | 3 | ctd:D006914 | |
| Drug | NSC86000 | 7.52e-06 | 5 | 209 | 3 | CID000257630 | |
| Drug | cresolphthalein | 7.52e-06 | 5 | 209 | 3 | ctd:C010092 | |
| Drug | Lobelanidine hydrochloride [6112-86-3]; Down 200; 10.6uM; PC3; HT_HG-U133A | EPHB3 PLXND1 ITPR1 SCN8A SCAPER GOLGB1 SUV39H2 SLC1A4 STS ABCB9 | 1.08e-05 | 190 | 209 | 10 | 5080_DN |
| Drug | APETx1, Anthopleura elegantissima | 1.49e-05 | 6 | 209 | 3 | ctd:C475726 | |
| Drug | Estazolam | 1.49e-05 | 6 | 209 | 3 | ctd:D004949 | |
| Drug | Glipizide | 1.49e-05 | 6 | 209 | 3 | ctd:D005913 | |
| Drug | acenaphthene-1-ol | 1.49e-05 | 6 | 209 | 3 | ctd:C023723 | |
| Drug | Medazepam | 1.49e-05 | 6 | 209 | 3 | ctd:D008472 | |
| Drug | S(-)-terguride hydrogen maleate [37686-85-4]; Up 200; 8.8uM; MCF7; HT_HG-U133A | IL18 ITIH2 SNX13 ABCB1 SCAPER ERO1B PCDHA5 ABCB9 MCOLN3 SOS2 | 1.55e-05 | 198 | 209 | 10 | 6473_UP |
| Drug | mantATP | 1.61e-05 | 35 | 209 | 5 | CID000123756 | |
| Drug | 4-hydroxyequilenin-o-quinone | 2.60e-05 | 7 | 209 | 3 | ctd:C117714 | |
| Drug | zomepirac | 2.60e-05 | 7 | 209 | 3 | ctd:C020549 | |
| Drug | Nitrazepam | 4.13e-05 | 8 | 209 | 3 | ctd:D009567 | |
| Drug | androsterone glucuronide | 4.50e-05 | 43 | 209 | 5 | CID000114833 | |
| Drug | verapamil | ABCA1 MYO5B ABCA13 ABCB1 ITPR1 SCN4A SCN5A SCN10A KCNN2 ALOX5 APOB CRH ABCB9 RNH1 ATP2B4 | 5.08e-05 | 490 | 209 | 15 | CID000002520 |
| Drug | 4-hydroxybenzoic acid | 6.15e-05 | 9 | 209 | 3 | ctd:C038193 | |
| Drug | 20-alpha-Dihydroprogesterone | 6.15e-05 | 9 | 209 | 3 | ctd:D004092 | |
| Drug | cyclaine | 6.15e-05 | 9 | 209 | 3 | CID000010770 | |
| Drug | Mexiletine | 6.15e-05 | 9 | 209 | 3 | ctd:D008801 | |
| Drug | Pregnanolone | 7.50e-05 | 25 | 209 | 4 | ctd:D011280 | |
| Drug | Ethynodiol diacetate [297-76-7]; Up 200; 10.4uM; PC3; HT_HG-U133A | 7.70e-05 | 193 | 209 | 9 | 6678_UP | |
| Drug | Hexylcaine | 8.39e-05 | 2 | 209 | 2 | DB00473 | |
| Drug | alpha-methylcinnamic acid | 8.39e-05 | 2 | 209 | 2 | ctd:C510582 | |
| Drug | Flecainide | 8.39e-05 | 2 | 209 | 2 | DB01195 | |
| Drug | CHEMBL83995 | 8.39e-05 | 2 | 209 | 2 | CID009571169 | |
| Drug | (10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE | 8.39e-05 | 2 | 209 | 2 | DB07768 | |
| Drug | baccharin | 8.39e-05 | 2 | 209 | 2 | ctd:C012764 | |
| Drug | Tetracycline hydrochloride [64-75-5]; Up 200; 8.4uM; PC3; HT_HG-U133A | 8.67e-05 | 196 | 209 | 9 | 5757_UP | |
| Drug | Iodipamide [606-17-7]; Up 200; 3.6uM; MCF7; HT_HG-U133A | 8.67e-05 | 196 | 209 | 9 | 5510_UP | |
| Drug | octyl gallate | 8.73e-05 | 10 | 209 | 3 | ctd:C016627 | |
| Drug | Florfenicol [73231-34-2]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 9.01e-05 | 197 | 209 | 9 | 5300_UP | |
| Drug | Amphotericin B [1397-89-3]; Up 200; 4.4uM; MCF7; HT_HG-U133A | 9.01e-05 | 197 | 209 | 9 | 3303_UP | |
| Drug | Deferoxamine mesylate [138-14-7]; Up 200; 6uM; MCF7; HT_HG-U133A | 9.37e-05 | 198 | 209 | 9 | 3842_UP | |
| Drug | Paroxetine maleate [64006-44-6]; Up 200; 1uM; MCF7; HT_HG-U133A | 9.37e-05 | 198 | 209 | 9 | 3904_UP | |
| Drug | Tyloxapol [25301-02-4]; Up 200; 4uM; PC3; HT_HG-U133A | 9.37e-05 | 198 | 209 | 9 | 4611_UP | |
| Drug | Betahistine mesylate [54856-23-4]; Up 200; 17.2uM; HL60; HT_HG-U133A | 9.37e-05 | 198 | 209 | 9 | 2472_UP | |
| Drug | Niacin [59-67-6]; Up 200; 32.4uM; MCF7; HT_HG-U133A | 9.37e-05 | 198 | 209 | 9 | 3381_UP | |
| Drug | Foliosidine [2520-38-9]; Up 200; 13uM; PC3; HT_HG-U133A | 9.37e-05 | 198 | 209 | 9 | 3739_UP | |
| Drug | PHA-00745360 [351320-33-7]; Down 200; 1uM; PC3; HT_HG-U133A | 9.73e-05 | 199 | 209 | 9 | 4562_DN | |
| Drug | plakin | 1.09e-04 | 82 | 209 | 6 | CID000018752 | |
| Drug | Dihydroxydihydrobenzopyrenes | 1.19e-04 | 11 | 209 | 3 | ctd:D004101 | |
| Drug | chlordecone alcohol | 1.19e-04 | 11 | 209 | 3 | CID000013946 | |
| Drug | oxovanadium | 1.23e-04 | 120 | 209 | 7 | CID000024411 | |
| Drug | Azacitidine | PCDHA9 PLS3 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.29e-04 | 415 | 209 | 13 | ctd:D001374 |
| Disease | 1,5 anhydroglucitol measurement | PCDHA9 MCM6 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 3.17e-23 | 29 | 207 | 14 | EFO_0008009 |
| Disease | visceral adipose tissue measurement, body mass index | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 4.42e-14 | 87 | 207 | 13 | EFO_0004340, EFO_0004765 |
| Disease | neutrophil count, basophil count | PCDHA9 ABO TGFBRAP1 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 6.91e-11 | 224 | 207 | 15 | EFO_0004833, EFO_0005090 |
| Disease | post-traumatic stress disorder symptom measurement | SYNE1 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 NBEA PCDHA3 PCDHA2 PCDHA1 | 3.20e-10 | 82 | 207 | 10 | EFO_0008535 |
| Disease | neuroticism measurement, cognitive function measurement | PCDHA9 CAB39L KALRN PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 GRM3 TG AFG1L | 1.18e-07 | 566 | 207 | 18 | EFO_0007660, EFO_0008354 |
| Disease | Abnormality of refraction | PCDHA9 MYO5B PKD1L1 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 NBEA PCDHA3 PCDHA2 PCDHA1 LRRC4C GRM3 DENND3 | 3.23e-07 | 673 | 207 | 19 | HP_0000539 |
| Disease | Neoplasms, Hormone-Dependent | 3.40e-07 | 3 | 207 | 3 | C0027661 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 4.78e-07 | 10 | 207 | 4 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 4.78e-07 | 10 | 207 | 4 | DOID:0080422 (implicated_via_orthology) | |
| Disease | vital capacity | EPHB3 PCDHA9 ABO PRSS16 SNX13 ITPR1 DST DLG1 CAB39L SYNE1 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 APOB PCDHA1 SKI HMCN1 SOS2 | 6.35e-07 | 1236 | 207 | 26 | EFO_0004312 |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 1.11e-06 | 12 | 207 | 4 | DOID:0060170 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 2.43e-06 | 163 | 207 | 9 | DOID:1826 (implicated_via_orthology) | |
| Disease | Intersex Conditions | 3.37e-06 | 5 | 207 | 3 | C2930618 | |
| Disease | Sex Differentiation Disorders | 3.37e-06 | 5 | 207 | 3 | C2930619 | |
| Disease | Hermaphroditism | 3.37e-06 | 5 | 207 | 3 | C0019269 | |
| Disease | Ambiguous Genitalia | 3.37e-06 | 5 | 207 | 3 | C0266362 | |
| Disease | Pseudohermaphroditism | 3.37e-06 | 5 | 207 | 3 | C0033804 | |
| Disease | pulse pressure measurement | PCDHA9 ABO TTC16 GPR101 TRPM3 SCN10A LETM2 PCDHA13 PCDHA12 PCDHA11 RRP15 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 NBEA PCDHA3 PCDHA2 PCDHA1 COLEC10 RNF126 SBF2 SLIT3 SOS2 | 5.56e-06 | 1392 | 207 | 26 | EFO_0005763 |
| Disease | Disorders of Sex Development | 1.17e-05 | 7 | 207 | 3 | C0036875 | |
| Disease | post-traumatic stress disorder | PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 ZWINT | 1.39e-05 | 202 | 207 | 9 | EFO_0001358 |
| Disease | Alzheimer disease, gastroesophageal reflux disease | 3.60e-05 | 228 | 207 | 9 | EFO_0003948, MONDO_0004975 | |
| Disease | level of plexin-D1 in blood serum | 4.90e-05 | 2 | 207 | 2 | OBA_2042940 | |
| Disease | Schizophrenia | ABCA1 IL18 HDAC4 MYO5B PRSS16 ABCA13 PTGER3 ABCB1 NRXN3 MLC1 DLG1 APOL2 NTRK3 GRM1 GRM3 CRH SLIT3 B3GAT1 | 5.58e-05 | 883 | 207 | 18 | C0036341 |
| Disease | Intellectual Disability | PUS3 HDAC4 DDX6 TRPM3 SCN8A SCAPER DYNC1H1 SYNE1 NBEA SLC1A4 MACF1 HTT | 8.26e-05 | 447 | 207 | 12 | C3714756 |
| Disease | phospholipids:total lipids ratio, intermediate density lipoprotein measurement | 1.10e-04 | 67 | 207 | 5 | EFO_0008595, EFO_0020946 | |
| Disease | neutrophil count | PCDHA9 ABO MCM6 PSPH SNX13 IFIH1 TGFBRAP1 WASHC2C PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 GPAM PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 SBF2 HTT | 1.16e-04 | 1382 | 207 | 23 | EFO_0004833 |
| Disease | mucolipidosis type IV (implicated_via_orthology) | 1.46e-04 | 3 | 207 | 2 | DOID:0080490 (implicated_via_orthology) | |
| Disease | PR interval | EFCAB5 TRPM3 SCN5A SCN10A DLG1 CAB39L CAMTA1 KALRN PCDHA4 LRRC4C SKI MACF1 | 2.13e-04 | 495 | 207 | 12 | EFO_0004462 |
| Disease | aspartate aminotransferase measurement | ABCA1 ABO MCM6 FYCO1 SNX13 ABCB1 ITPR1 TRPM3 APOL2 KLRC3 KALRN GPAM NUP214 SKIL USP8 SEPTIN10 SOS2 | 2.34e-04 | 904 | 207 | 17 | EFO_0004736 |
| Disease | glycoproteinosis (implicated_via_orthology) | 2.91e-04 | 4 | 207 | 2 | DOID:3343 (implicated_via_orthology) | |
| Disease | Brugada ECG Pattern | 2.91e-04 | 4 | 207 | 2 | C1721096 | |
| Disease | lipoprotein measurement, phospholipid measurement | 3.37e-04 | 85 | 207 | 5 | EFO_0004639, EFO_0004732 | |
| Disease | Cerebellar Ataxia | 4.83e-04 | 5 | 207 | 2 | C0007758 | |
| Disease | Hypoplastic Left Heart Syndrome | 4.83e-04 | 5 | 207 | 2 | C0152101 | |
| Disease | Unipolar Depression | 5.15e-04 | 259 | 207 | 8 | C0041696 | |
| Disease | total phospholipids in lipoprotein particles measurement | 5.26e-04 | 53 | 207 | 4 | EFO_0022315 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol consumption measurement | 6.79e-04 | 99 | 207 | 5 | EFO_0004611, EFO_0007878 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 6.86e-04 | 150 | 207 | 6 | EFO_0004611, EFO_0020947 | |
| Disease | Cushing Syndrome | 7.21e-04 | 6 | 207 | 2 | C0010481 | |
| Disease | cortolone glucuronide (1) measurement | 7.21e-04 | 6 | 207 | 2 | EFO_0800552 | |
| Disease | triglyceride measurement, alcohol consumption measurement | 7.43e-04 | 101 | 207 | 5 | EFO_0004530, EFO_0007878 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol drinking | 7.77e-04 | 102 | 207 | 5 | EFO_0004329, EFO_0004611 | |
| Disease | brain ischemia (biomarker_via_orthology) | 7.77e-04 | 102 | 207 | 5 | DOID:2316 (biomarker_via_orthology) | |
| Disease | cholesterol to total lipids in IDL percentage | 8.44e-04 | 60 | 207 | 4 | EFO_0022233 | |
| Disease | electrocardiography, PR interval | 1.00e-03 | 7 | 207 | 2 | EFO_0004327, EFO_0004462 | |
| Disease | leucine-rich repeat-containing protein 15 measurement | 1.00e-03 | 7 | 207 | 2 | EFO_0801761 | |
| Disease | phospholipids:total lipids ratio | 1.16e-03 | 227 | 207 | 7 | EFO_0020946 | |
| Disease | diet measurement | ABO PRSS16 MCM6 KCTD1 PTGER3 ITPR1 NWD2 NRXN3 DST NGEF EXOC6B PKHD1 CAMTA1 FERMT3 APOB LRRC4C CAPZA3 | 1.23e-03 | 1049 | 207 | 17 | EFO_0008111 |
| Disease | Mood Disorders | 1.23e-03 | 168 | 207 | 6 | C0525045 | |
| Disease | Grand Mal Status Epilepticus | 1.28e-03 | 67 | 207 | 4 | C0311335 | |
| Disease | Petit mal status | 1.28e-03 | 67 | 207 | 4 | C0270823 | |
| Disease | Complex Partial Status Epilepticus | 1.28e-03 | 67 | 207 | 4 | C0393734 | |
| Disease | Status Epilepticus, Subclinical | 1.28e-03 | 67 | 207 | 4 | C0751522 | |
| Disease | Simple Partial Status Epilepticus | 1.28e-03 | 67 | 207 | 4 | C0751524 | |
| Disease | Non-Convulsive Status Epilepticus | 1.28e-03 | 67 | 207 | 4 | C0751523 | |
| Disease | temporal lobe epilepsy (biomarker_via_orthology) | 1.32e-03 | 31 | 207 | 3 | DOID:3328 (biomarker_via_orthology) | |
| Disease | cardiac arrest (biomarker_via_orthology) | 1.33e-03 | 8 | 207 | 2 | DOID:0060319 (biomarker_via_orthology) | |
| Disease | familial hyperlipidemia (is_implicated_in) | 1.33e-03 | 8 | 207 | 2 | DOID:1168 (is_implicated_in) | |
| Disease | FEV change measurement, fatty liver disease | 1.33e-03 | 8 | 207 | 2 | EFO_0005921, MONDO_0004790 | |
| Disease | allergic rhinitis (is_implicated_in) | 1.33e-03 | 8 | 207 | 2 | DOID:4481 (is_implicated_in) | |
| Disease | lactase-phlorizin hydrolase measurement | 1.33e-03 | 8 | 207 | 2 | EFO_0801753 | |
| Disease | Status Epilepticus | 1.35e-03 | 68 | 207 | 4 | C0038220 | |
| Disease | Rheumatoid Arthritis | 1.48e-03 | 174 | 207 | 6 | C0003873 | |
| Disease | urate measurement, bone density | ITPR1 FSIP2 MLC1 A2ML1 DNAH8 DNAH9 FAM234B SYNE1 LRRC4C TG SEPTIN10 ATP2B4 | 1.51e-03 | 619 | 207 | 12 | EFO_0003923, EFO_0004531 |
| Disease | Contact hypersensitivity | 1.58e-03 | 71 | 207 | 4 | C0162351 | |
| Disease | Contact Dermatitis | 1.58e-03 | 71 | 207 | 4 | C0011616 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 1.67e-03 | 121 | 207 | 5 | EFO_0008595, EFO_0020943 | |
| Disease | sleep duration, high density lipoprotein cholesterol measurement | 1.67e-03 | 121 | 207 | 5 | EFO_0004612, EFO_0005271 | |
| Disease | cholesteryl ester measurement, high density lipoprotein cholesterol measurement | 1.70e-03 | 312 | 207 | 8 | EFO_0004612, EFO_0010351 | |
| Disease | Situs ambiguous | 1.71e-03 | 9 | 207 | 2 | C1167664 | |
| Disease | familial Mediterranean fever (is_implicated_in) | 1.71e-03 | 9 | 207 | 2 | DOID:2987 (is_implicated_in) | |
| Disease | pulmonary sarcoidosis (is_implicated_in) | 1.71e-03 | 9 | 207 | 2 | DOID:13406 (is_implicated_in) | |
| Disease | supraventricular ectopy | 1.71e-03 | 9 | 207 | 2 | EFO_0009277 | |
| Disease | total cholesterol measurement, high density lipoprotein cholesterol measurement | 1.80e-03 | 315 | 207 | 8 | EFO_0004574, EFO_0004612 | |
| Disease | phospholipid measurement, high density lipoprotein cholesterol measurement | 2.03e-03 | 321 | 207 | 8 | EFO_0004612, EFO_0004639 | |
| Disease | Behcet's disease (is_implicated_in) | 2.05e-03 | 36 | 207 | 3 | DOID:13241 (is_implicated_in) | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 2.06e-03 | 127 | 207 | 5 | EFO_0008595, EFO_0020947 | |
| Disease | Bipolar Disorder | 2.10e-03 | 477 | 207 | 10 | C0005586 | |
| Disease | vesicular integral-membrane protein VIP36 measurement | 2.12e-03 | 10 | 207 | 2 | EFO_0022012 | |
| Disease | Hashish Abuse | 2.12e-03 | 10 | 207 | 2 | C0018614 | |
| Disease | Cannabis Abuse | 2.12e-03 | 10 | 207 | 2 | C0006868 | |
| Disease | Cannabis-Related Disorder | 2.12e-03 | 10 | 207 | 2 | C0236735 | |
| Disease | Mental Depression | 2.19e-03 | 254 | 207 | 7 | C0011570 | |
| Disease | diverticulitis | 2.22e-03 | 37 | 207 | 3 | EFO_1001460 | |
| Disease | bone mineral content measurement | 2.28e-03 | 130 | 207 | 5 | EFO_0007621 | |
| Disease | body fat percentage | 2.48e-03 | 488 | 207 | 10 | EFO_0007800 | |
| Disease | Global developmental delay | 2.52e-03 | 133 | 207 | 5 | C0557874 | |
| Disease | leptin measurement | 2.57e-03 | 81 | 207 | 4 | EFO_0005000 | |
| Disease | invasive ductal carcinoma (is_implicated_in) | 2.58e-03 | 11 | 207 | 2 | DOID:3008 (is_implicated_in) | |
| Disease | cryptorchidism (biomarker_via_orthology) | 2.58e-03 | 11 | 207 | 2 | DOID:11383 (biomarker_via_orthology) | |
| Disease | Situs Inversus | 2.58e-03 | 11 | 207 | 2 | C0037221 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 2.72e-03 | 264 | 207 | 7 | EFO_0008317, EFO_0020944 | |
| Disease | invasive ductal carcinoma (is_marker_for) | 2.78e-03 | 40 | 207 | 3 | DOID:3008 (is_marker_for) | |
| Disease | sudden cardiac arrest | 2.81e-03 | 83 | 207 | 4 | EFO_0004278 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 2.97e-03 | 200 | 207 | 6 | EFO_0004611, EFO_0020945 | |
| Disease | Candidemia | 3.09e-03 | 12 | 207 | 2 | EFO_1001282 | |
| Disease | cholesteryl esters to total lipids in small LDL percentage | 3.19e-03 | 42 | 207 | 3 | EFO_0022255 | |
| Disease | pulmonary tuberculosis (is_implicated_in) | 3.19e-03 | 42 | 207 | 3 | DOID:2957 (is_implicated_in) | |
| Disease | depressive symptom measurement | PRSS16 PTGER3 PKHD1 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 3.30e-03 | 426 | 207 | 9 | EFO_0007006 |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 3.54e-03 | 144 | 207 | 5 | EFO_0004611, EFO_0020943 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AGFAVNLRLILQRSQ | 256 | Q9P2W7 | |
| VNQAQLALSFARLVE | 216 | Q96KX2 | |
| DVTQIFNNILRRQIG | 96 | Q9H9S4 | |
| EILELVNNRIFQSRF | 986 | O14727 | |
| NTLFSRLQINQSIIF | 326 | P26196 | |
| FQDQVSRENLLQLLT | 16 | Q9BQE5 | |
| IQLLSATNQFQRQAA | 1216 | Q6ZSZ5 | |
| GLVTLQVAFNNQIIS | 931 | Q9Y6Y1 | |
| QLRLVFQEFQNISGQ | 206 | Q9UJ72 | |
| ELLQELLQRQIQNTF | 231 | Q6P047 | |
| LLQRQIQNTFAILDL | 236 | Q6P047 | |
| NIDILNEQFRLQNTT | 101 | P16442 | |
| NEQFRLQNTTIGLTV | 106 | P16442 | |
| NFVQILSNLLAEENR | 711 | O14514 | |
| RIRQNVQVFEFQLTA | 276 | P42330 | |
| RVINIFQSNLFQALI | 36 | Q12959 | |
| GFQLTRQEIVALLNA | 431 | Q86YB8 | |
| SSVSIQVANLLRLFQ | 151 | Q14832 | |
| AISSFLNVINNAILR | 1601 | O95477 | |
| NFQRTFNIQSVNRLV | 1271 | A8K2U0 | |
| LLQEANITIQLFINR | 2836 | Q8WXG9 | |
| NITIQLFINREFGSL | 2841 | Q8WXG9 | |
| IFLRNIPQFTLANRT | 371 | Q8WV93 | |
| LLQIQALFQRSGDQL | 36 | Q5T686 | |
| VQLLFENILINLINN | 2201 | Q86UQ4 | |
| VALNRFQALQSVDIL | 3431 | Q86UQ4 | |
| NQFILLVLFLLQIQS | 11 | Q9Y6Z7 | |
| NVNNIVGIRNTFLLR | 281 | Q6PIY7 | |
| SRVFTLQVQGLLQLQ | 256 | Q5T7M4 | |
| ELERQFLELLQFNIN | 251 | Q8ND76 | |
| LAAQTFIQRVQSLQL | 311 | A2RUS2 | |
| DLENAFLNLVQRIQN | 251 | A6NMY6 | |
| ILNIIEIFENINFQF | 491 | Q6P1M9 | |
| GLNRIQTQIDVINTF | 1096 | P23634 | |
| LLFAINSRRQQIVEF | 171 | Q9H560 | |
| VSLLLQQNINIFSQD | 216 | Q9H560 | |
| NLFRINGQRISQLLI | 1391 | Q9ULI1 | |
| SERVFLQNNRIGLLQ | 56 | Q86UN2 | |
| VNIIVFRQINQFDLS | 1046 | P69849 | |
| EVNLQNGILFVNSRI | 76 | Q9Y5H5 | |
| QAIIIVFNLNDVASL | 126 | Q9BZG1 | |
| EVNLQNGILFVNSRI | 76 | Q9Y5H9 | |
| EVNLQNGILFVNSRI | 76 | Q9UN73 | |
| VTVQLILFGLSNQLA | 76 | Q9GZU1 | |
| TIQNADLIVVFQNGR | 1236 | P08183 | |
| TIQVQGQALFFREAL | 11 | Q96IU4 | |
| FQRQNVTSFRNITQL | 151 | Q6IE37 | |
| EVNLQNGILFVNSRI | 76 | Q9UN72 | |
| AFQIRQFQRSLLNLL | 956 | Q9NVI1 | |
| EVNLQNGILFVNSRI | 76 | Q9Y5I1 | |
| LVVSFVDLEQFNQQL | 61 | Q14566 | |
| VNIIVFRQINQFDLS | 1046 | Q5JPE7 | |
| EVSLQNGILFVNSRI | 76 | Q9Y5H6 | |
| EVNLQNGILFVNSRI | 76 | Q9Y5H8 | |
| LELQTFGTNNLLRFQ | 301 | Q2VYF4 | |
| NLQALTFLNISRNQL | 126 | Q96II8 | |
| RFNENLRDAVQLNVI | 116 | Q8WVX9 | |
| NVQRVLEAANLFQFL | 141 | Q8WZ60 | |
| QELLFRQQALLLEQQ | 586 | P56524 | |
| SNIQVLLQAAEFLER | 6 | Q9BW11 | |
| QQFLERTQALEAQIV | 406 | Q92805 | |
| NLEVLRSFQNQIAAI | 571 | Q8N201 | |
| TNINEALLRAIFILN | 386 | P19823 | |
| SVIRGLQLQQEFVNF | 306 | Q8TDD5 | |
| LFQTLSLRELQLEQN | 146 | Q16288 | |
| QLLFRHFSQRQEVLQ | 1091 | Q14643 | |
| LLFQQLGIQNVLSLF | 201 | Q86WG5 | |
| SEEARSLIQQLLQFN | 1021 | Q96S38 | |
| GLISQTIRQQQRDFI | 526 | Q9H2S1 | |
| NQFGDSQQLRLVRIL | 7311 | Q03001 | |
| LTRQLQFLETQLAQV | 511 | Q9BQS8 | |
| LQLFFVIRNTRQLGD | 551 | O60303 | |
| FEQLLVALRGNQNQR | 126 | Q8N6Q8 | |
| EIRAFNTLSQNQILV | 71 | Q8ND23 | |
| RILANTNTDQLFTVN | 76 | Q8NA75 | |
| IRNILNEIFQSTLIN | 1781 | Q5CZC0 | |
| NEIFQSTLINQLNVL | 1786 | Q5CZC0 | |
| SAVINEIFQRQVNLI | 5951 | Q5CZC0 | |
| QFLISLVQSNRILGV | 191 | Q00613 | |
| FIIQENLNLALNSAS | 191 | P13797 | |
| IQVGNFNQTIATLQL | 1251 | Q9Y4D7 | |
| LNSVQVLERLQQRGF | 201 | Q719H9 | |
| NFFLIAVRLASLNQI | 326 | P43115 | |
| IQAVALRDIFVQAQN | 336 | A2RU67 | |
| ILSSQQALQLLQRFQ | 451 | Q96JB1 | |
| NIRLNQRFSITAQLL | 636 | Q9H0H0 | |
| INQVLETQRDFLNAL | 2221 | O60229 | |
| GRQLTIFNTQAQIAI | 1206 | Q9Y4C0 | |
| VNIIVFRQINQFDLS | 1046 | Q15155 | |
| QELRSRNFQQLSVDV | 376 | Q8NG66 | |
| GTQTLFLQDNNIARL | 51 | Q50LG9 | |
| LLSQNVEGIQQFQLR | 396 | Q8TB73 | |
| TLFNTLANNREIINQ | 856 | P35658 | |
| SFLRLNDGQFTVIQL | 721 | P54753 | |
| QVARQFLLQQASGLS | 71 | Q8IVH2 | |
| RFLSLAGNQIRQVEN | 91 | Q96FV0 | |
| QVIERNAFDNLQSLV | 256 | Q9HCJ2 | |
| NAFDNLQSLVEINLA | 261 | Q9HCJ2 | |
| AEVRQLTLGALQQFN | 686 | Q9Y2D4 | |
| QLLQVTNRFIFNLLV | 61 | Q96P66 | |
| VNNRVFSNVSIILFL | 276 | Q14344 | |
| VNLQNGILFVNSRID | 76 | Q9Y5H7 | |
| QATANFFRVLLQQLL | 106 | P06850 | |
| FLALVLNLLQIQRNV | 41 | Q9Y5U4 | |
| LSQQTALFAEIERNQ | 1316 | Q9UPN3 | |
| FLSNGRILQILNTQI | 2921 | Q96RW7 | |
| EVNLQNGILFVNSRI | 76 | Q9Y5I3 | |
| EVNLQNGILFVNSRI | 76 | Q9Y5I0 | |
| VNLQNGILFVNSRID | 76 | Q9Y5I2 | |
| EVNLQNGILFVNSRI | 76 | Q9UN74 | |
| EQFILSQVALLEQVN | 91 | O75935 | |
| FSQNAFQVRQRLLLE | 861 | A4FU69 | |
| LRNLQDLLQFIFQLI | 4296 | P04114 | |
| LLVTQLGRFTAQDQQ | 116 | Q8WWP7 | |
| NVVTGALELLQQLFR | 371 | P42858 | |
| NQETNQLFEGVLLTL | 3811 | Q8TD57 | |
| LTSNFQAIRVTLNIN | 216 | Q9H2C2 | |
| EISLLQAQVSNFQRE | 351 | Q96C92 | |
| RLNLQEGLQTFFVLQ | 6 | Q6ZPD8 | |
| QNNRIFQTLLEVSAS | 396 | A4D1U4 | |
| FLNVLRQTGNNELVQ | 181 | Q9BYX4 | |
| NNIVSSLQRNGIFIN | 6 | Q5JW98 | |
| QGLSQDLRNQICFQL | 336 | Q96D53 | |
| QLNIQIREVFANRFT | 511 | Q6IQ26 | |
| NSLIRVLQTLQEFNI | 1261 | Q6IQ26 | |
| QEQQLFELFVVVSLQ | 486 | Q68D51 | |
| GLFLASDVQQLRQAI | 136 | Q6ZN54 | |
| LQQANIQFRTDIART | 3536 | Q14204 | |
| ADQQNFTVTLDQVLL | 451 | Q05932 | |
| QLFSQLTLLQQELFQ | 1471 | Q76NI1 | |
| QQALESVSLRFLQNT | 2986 | Q9NYC9 | |
| SVAIQVQNLLQLFDI | 166 | Q13255 | |
| SVIRNLNDQVLFIDQ | 46 | Q14116 | |
| NGIRFVNTFNELITI | 486 | P46059 | |
| NTIQVAIQSLRFFNS | 1211 | Q9BY12 | |
| NNVSASTLRQQLFIV | 656 | Q8TDX9 | |
| AVSFQLQLQLQEAVQ | 366 | Q0P6D2 | |
| FQRVQALTTNLNLIL | 256 | Q659C4 | |
| LIRVSQLQIQFQGGF | 56 | Q86WQ0 | |
| FQILLQNPLQFVTNE | 106 | Q9Y5E6 | |
| EVNLQNGILFVNSRI | 76 | Q9UN75 | |
| IVSLLLQQNIDVFSQ | 246 | Q6S8J7 | |
| QVLLENPLQFFQASL | 106 | Q9Y5E3 | |
| VFILQAVLQLASQEA | 221 | Q8NGK4 | |
| QVNNITEFILLGLTQ | 26 | Q8NGB2 | |
| TNDNIQIVLAIFENI | 1331 | Q5JY77 | |
| LEIRQTLQNALIQFA | 131 | Q9Y5W8 | |
| NFQRTILSAQVQLVG | 236 | Q9BZE2 | |
| SRIIEILQVFQDLNN | 851 | Q07890 | |
| TLNLFIGVIIDNFNQ | 1286 | P35499 | |
| LNSVLREFTLQQINT | 171 | P12757 | |
| QVAQLEQALEQFSAL | 2961 | Q8NF91 | |
| FQAVNSRIQLQILEA | 361 | Q8N9U0 | |
| NVFSNLRQLQVLILS | 311 | Q8TF66 | |
| LSLEQEVQQGNIFIV | 271 | P09917 | |
| ILLASNLAQFLTQEQ | 86 | Q86YW0 | |
| GINQRALQLLFSEVQ | 546 | Q9BVG8 | |
| GRQLTIFNTQAQIAI | 201 | Q9HDB5 | |
| VAQIFGLRNLLANVD | 176 | P22732 | |
| VLFPLFAQLDNRQLN | 501 | Q8NFP9 | |
| QQQFLEIFLEGTRSR | 306 | Q9HCL2 | |
| LQSTLLREIQQFSQG | 461 | Q6NW34 | |
| QGQTLANVFILRLLE | 556 | Q8N5V2 | |
| LDAIITQLLNQFENT | 186 | Q9BV68 | |
| TLNLFIGVIIDNFNQ | 1461 | Q14524 | |
| INLQLLFLNNNLLRS | 471 | Q9H156 | |
| TQRLTVEAAQFIQRN | 261 | P08842 | |
| IFRNGIALEILQNTS | 241 | O15389 | |
| DQGTTVIFQERQLQI | 61 | Q96LZ7 | |
| QEIFQVELNLQNASL | 36 | Q07444 | |
| LERLTNFLQIGQNQI | 3581 | P08F94 | |
| NLLVVETSARFNVNI | 221 | Q13017 | |
| VLQQFSQLVNGDVAL | 106 | Q9H6T0 | |
| SNLTGFQNLEILNFR | 941 | Q9BZV3 | |
| FQNLEILNFRNGSIV | 946 | Q9BZV3 | |
| ILNSVLRDFSLQQIN | 126 | P12755 | |
| SLEINRQFAGQINLL | 511 | Q92502 | |
| QLQQALELQLFLSSV | 2571 | Q9NRC6 | |
| LRQLQAFLQDSQEVA | 2681 | Q9NRC6 | |
| SSQELILRRGQNFQV | 26 | Q08188 | |
| EGRLQSIFQVLLQSQ | 71 | Q96SE0 | |
| VSDLVSQNINVFLRN | 296 | Q9NP78 | |
| RIRQNVQVFEFQLTS | 276 | Q04828 | |
| RIRQNVQVFEFQLTS | 276 | P52895 | |
| LNQAGQLFLLQTVEL | 326 | A8K7I4 | |
| VNTFQDLQNLNLLSL | 396 | O75094 | |
| INIDRFAFQNLTQLR | 276 | Q9NR97 | |
| RILQQAGFIQFAQLQ | 351 | Q8WUH2 | |
| QLQVADFLQNILAQE | 56 | O95229 | |
| VDFIFEQVQNVLQSL | 21 | Q96T68 | |
| QEAFQAQRSQLVELL | 31 | Q9HC29 | |
| SRLQERNVQVFLISG | 96 | P78330 | |
| IAQDRNIAIQSQFTR | 101 | P12270 | |
| SQVLFALNQTLLQQE | 221 | A6NFA1 | |
| LNNVELNAGQIFTIL | 396 | P43007 | |
| EVNNLQVALARIQVF | 906 | Q9Y5Y9 | |
| NQVLNRVTAERNLFD | 1116 | Q5XPI4 | |
| NILLVNLLIAVFNNT | 1126 | Q9HCF6 | |
| NLQVFNVFIDNLDTR | 336 | Q9H5I1 | |
| LENNFRQILFLIEQI | 116 | Q8TAQ9 | |
| DNETLRQITNFQLSI | 376 | P15498 | |
| RQITNFQLSIENLDQ | 381 | P15498 | |
| LVRLSVLQQELNAFT | 476 | O94964 | |
| HQQTFLNQLREITGI | 16 | Q9UHP3 | |
| VLAQNRFLLELQISN | 336 | P13489 | |
| LNLFIGVIIDNFNQQ | 1456 | Q9UQD0 | |
| ILGETEVQQFLRQAQ | 61 | Q96DC7 | |
| EAVQVFLQQSGLQAL | 456 | Q96DC7 | |
| FALNQTLLQQESLRA | 226 | Q86V40 | |
| AGLLQFLQEFSQQTI | 41 | Q9Y4E1 | |
| LDVFNIILARQQAQV | 436 | Q709C8 | |
| VAQLSLAEAQLRFIQ | 531 | Q86UX7 | |
| NLQRIATRGVVQLFN | 161 | Q9Y3B9 | |
| LVNRSIQQGFCFNIL | 56 | Q9P0V9 | |
| AGLLQFLQEFSQQTI | 41 | Q641Q2 | |
| VNLQSISEFIINNRN | 181 | Q9Y2H8 | |
| QLLQNIFGARQDVAT | 451 | Q8NEE8 | |
| LLATNEVLLEQNAQF | 261 | Q96K80 | |
| QLQSEQAFLRTVQAL | 731 | P01266 | |
| ENQGLQIFIQVLETF | 556 | Q6WRX3 | |
| SLRLGRQNIFQQLQT | 486 | Q9NQE7 | |
| QLNESIIVALFQGQF | 916 | P40818 | |
| IDTSQFILNRLEQTQ | 71 | O60220 | |
| LVADRLLQFSTIQQN | 31 | Q0VDI3 | |
| LRIQQLNSNFSQLLE | 3046 | Q14789 | |
| SRRNANVIPNFQILF | 101 | Q15049 | |
| VAFIRTIQAQLQERN | 1791 | Q9ULV0 | |
| QLTAFALLQAQLRGQ | 31 | Q69YL0 |